3D bioprinted hydrogel scaffolds laden with Schwann cells for use as nerve repair conduits by Rajaram, Ajay
3D BIOPRINTED HYDROGEL SCAFFOLDS LADEN WITH SCHWANN CELLS FOR USE 
AS NERVE REPAIR CONDUITS 
 
 
 
 
 
 
 
 
 
A Thesis Submitted to the College of 
Graduate Studies and Research 
In Partial Fulfillment of the Requirements 
For the Degree of Doctor of Philosophy 
In the Division of Biomedical Engineering 
University of Saskatchewan 
Saskatoon 
 
By 
 
AJAY RAJARAM 
 
 
 
 
 
 
 
 Copyright Ajay Rajaram, June, 2015. All rights reserved. 
i 
PERMISSION TO USE 
 
In presenting this thesis in partial fulfilment of the requirements for a Postgraduate degree from 
the University of Saskatchewan, I agree that the Libraries of this University may make it freely 
available for inspection.  I further agree that permission for copying of this thesis in any manner, 
in whole or in part, for scholarly purposes may be granted by Prof. Daniel Chen and Prof. David 
Schreyer who supervised my thesis work or, in their absence, by the Head of the Division of 
Biomedical Engineering or the Dean of the College of Engineering in which my thesis work was 
done.  It is understood that any copying or publication or use of this thesis or parts thereof for 
financial gain shall not be allowed without my written permission.  It is also understood that due 
recognition shall be given to me and to the University of Saskatchewan in any scholarly use 
which may be made of any material in my thesis. 
Requests for permission to copy or to make other use of material in this thesis in whole or 
part should be addressed to: 
 
 Head of the Division of Biomedical Engineering 
 Room 2B60, 57 Campus Drive 
University of Saskatchewan 
 Saskatoon, Saskatchewan S7N 5A9 
Canada 
ii 
ABSTRACT 
 
The goal of nerve tissue engineering is to promote and guide axon growth across a site of 
nerve injury without misdirection. Bioengineered tissue scaffolds have been shown to be 
promising for the regeneration of damaged peripheral nerves. Schwann cells play a pivotal role 
following nerve injury by forming aligned “bands of Büngner” that promote and guide axon 
regeneration into the distal nerve segment. The incorporation of living Schwann cells into 
various hydrogels has therefore been urged during the fabrication of tissue engineered nerve 
scaffolds. The aim of this research is to characterize biomaterials suitable for 3D bioplotting of 
nerve repair scaffolds. Here a novel technique of scaffold fabrication has been optimized to print 
alginate-based three-dimensional tissue scaffolds containing hyaluronic acid and living Schwann 
cells. Alginate/hyaluronic acid scaffolds were successfully fabricated with good printability and 
cell viability. Addition of the polycation polyethyleneimine (PEI) during the fabrication process 
stabilized the structure of alginate through the formation of a polyelectrolyte complex and had a 
significant influence on the degree of swelling, degradation rate, mechanical property, and 
release kinetics of incorporated protein within the scaffolds. A preliminary in vivo study showed 
the feasibility of implanting 3D printed alginate/hyaluronic acid scaffolds as nerve conduits in 
Sprague-Dawley (SD) rats with resected sciatic nerves. However alginate/hyaluronic acid 
scaffolds were found to be unsuitable for axonal regeneration. Further in vitro culture of 
Schwann cells was performed in collagen type-I, fibrin, fibrin/hyaluronic acid, and their 
combination with alginate. It was found that Schwann cells had more favorable cell morphology 
in fibrin/hyaluronic acid or collagen without alginate. Schwann cell proliferation and alignment 
were better in fibrin/hyaluronic acid. Therefore fibrin/hyaluronic acid is more ideal than most 
other hydrogel formulations for use in the bioprinting of nerve repair tissue engineering 
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scaffolds, which incorporate cellular elements. As Schwann cells also align along the long axis 
of the printed fibrin/hyaluronic acid strands, 3D bioprinting of multiple layers of crosslinked 
fibrin strands can be used to fabricate a nerve conduit mimicking the bands of Büngner. 
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CHAPTER 1 
INTRODUCTION 
1.1 Peripheral Nerve Injury  
Injury to peripheral nerves occurs commonly due to trauma, compression, excessive 
stretching, and iatrogenic injury during surgical or anesthetic procedures. Trauma is the most 
common etiology and injuries to the nerve occur as a result of motor vehicle accidents, 
lacerations, limb fractures, and crush injuries (Robinson, 2000). In a retrospective analysis 
(Noble et al., 1998) of patients with nerve injury at the Sunnybrook Health Science Center 
(Toronto, ON, Canada) a decade ago, it was found that motor vehicles accidents was the 
predominant etiology. The radial nerve was the most frequently injured nerve in the upper 
extremity and the peroneal nerve in the lower extremity. Motor vehicle accidents was the 
predominating etiology in a more recent study completed at Turkey (Eser et al., 2009). Although 
peripheral nerve injuries are common in limb trauma, the overall incidence rate is still low 
(Taylor et al., 2008). Damage to peripheral nerves may also arise due to sprained joints (Nitz et 
al., 1985) and nerve sheath tumors (Ducatman et al., 1986). The endoneurium of the nerve is 
elastic due to its high collagen content; but excessive traction forces may induce avulsion of the 
nerve. Local infiltration of anesthetic agents can also inflict nerve damage (Cameron and 
Stewart, 1975); although the incidence of this serious complication after peripheral nerve 
blockade is not very common (Barrington et al., 2009) 
Injury to the peripheral nerve can affect either the axon or the myelin sheath. Crush or 
disruption of the axons lead to altered gene expression in the nerve cell body and degeneration of 
the distal segment and the axon terminal. Wallerian degeneration is the characteristic 
consequence at the distal end of the damaged nerve (Chaudhry et al., 1992). The events, 
occurring during regeneration, guide the newly spouted axons as they innervate the target organs. 
There is an ‘initial delay’, before the appearance of new axonal sprouts from the distal end 
(Sunderland, 1978). Czaja et al., (2008) had estimated this delay to be between 3–42 days. The 
initial axonal sprouts that are guided by Schwann cells are unmyelinated. 
Schwann cells proliferate rapidly and by day 3 (Stoll et al., 1989) rearrange themselves to 
form bands of Büngner, which form a vital guidance cue for the regenerating axon (Fawcett and 
Keynes, 1990). The elaborate arrangement of Schwann cells in the Büngner bands, serve as 
physical conduits, guiding axons to their targets. Son and Thompson, (1995) showed that axonal 
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regeneration is limited by the absence of processes from Schwann cells. Perry et al., (1987) 
established that macrophages invade damaged peripheral nerves and are localized around the 
damaged axons. These macrophages are recruited to phagocytize myelin and other debris even 
before maximal Schwann cell proliferation (Goodrum et al., 1994). Fernandez-Valle et al., 
(1995) showed the ability of Schwann cells in clearing myelin debris, in vitro. Schwann cells 
also produce various neurotrophins like BDNF, NT-3, NT-4/5, and NGF (Funakoshi et al., 
1993). Pellitteri et al., (2006) showed that Schwann cells enhanced the production of 
neurotrophins in cultures of neurons from rat embryonic cerebral cortex. Schwann cells have also 
been genetically modified, to overexpress BDNF and NT-3; thereby promoting spiral ganglion 
cell survival in vitro (Pettingill et al., 2008). 
Axonal advancement is also promoted by extracellular matrix components like laminin 
and fibronectin. Addition of anti-laminin-2 antibodies to a culture of embryonic chick sensory 
neurons reduced the growth and total length of the neurites (Agius and Cochard, 1998). The 
newly sprouted axons enlarge and attain close-to-normal diameters with a compensated increase 
in myelin sheath thickness, as they proceed towards the distal end (Sanders, 1948). There are 
many newly grown axonal fibers and that not in close proximity to the target are pruned away 
(McQuarrie, 1985). Thus extracellular matrix factors, Schwann cells and neurotrophins could be 
exploited and integrated into scaffolds for enhanced regenerative properties.  
 
1.2 Current clinical repair of injured peripheral nerves 
1.2.1 Epineural suturing 
Tension-free coaptation of transected nerves using non-absorbable sutures at the 
epineurium is the standard surgical repair technique (Rowshan et al., 2004). In a study by 
Murovic (2008), 25.7% of the patients with radial nerve injury at the Louisiana State University 
Health Sciences Center, between the years 1967 and 1997 were treated with sutures. Surgery is 
performed within a week to repair uncomplicated nerve injuries (Dvali and Mackinnon, 2003) or 
is delayed until 3-4 weeks in contusion or traction injuries. Coaptation could be epineural, 
fascicular, or grouped fascicular repair. In fascicular repair each individual fascicle is sutured to 
be continuous and in grouped fascicular repair, motor and sensory fascicular groups are 
identified and sutured separately. Although both fascicular and grouped fascicular repair lead to 
better alignment of the axons and reduce axonal misdirection (Brushart et al., 1983), additional 
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dissection and suturing compared to epineural repair can compromise blood supply (Ogata and 
Naito, 1986) and increase fibrotic tissue. Despite the advances in surgical techniques, complete 
functional recovery is rarely achievable (Siemionow and Brzezicki, 2009). 
 
1.2.2 Autografts 
Autologous nerve grafts are still considered to be the gold standard in repairing injured 
peripheral nerves (Deumens et al., 2010), as they provide a natural scaffold containing Schwann 
cells and their basal lamina. Schwann cells secrete various neurotrophic factors and the basal 
lamina contains many extracellular matrix proteins. It is known that the loss of Schwann cells in 
nerve conduits results in suppression of nerve regeneration (Hall, 1986). Therefore autografts 
provide an appropriate environment for regenerating axons. In a study by Murovic (2008), 33.9% 
of the patients with radial nerve injury at the Louisiana State University Health Sciences Center, 
between the years 1967 and 1997 were treated with grafts. 54 graft, 41 suture, 64 neurolysis. 159 
total  
Sensory cutaneous nerves such as the sural nerve, lateral antebrachial cutaneous nerve, 
medial antebrachial cutaneous nerve, dorsal cutaneous branch of ulnar nerve, and the superficial 
sensory branch of the radial nerve are commonly used donor nerves for autografting (Matsuyama 
et al., 2000). Donor nerves are sensory nerves as their harvest results in acceptable donor-site 
sensory loss. A donor nerve is chosen based on the caliber of the nerve to be repaired, defect 
length, and donor site morbidity. About 20 cm of the sural nerve can be harvested (Ortigüela et 
al., 1987).  
However, the need for a second surgery to obtain the donor nerve, loss of donor-site 
function, mismatch between the injured and donor nerve size, and neuroma formation, are 
setbacks of autografts. Harvesting the sural nerve can result in sensory loss along the lateral 
aspect of the foot in nearly 50% of the patients (Staniforth and Fisher, 1978) and neuroma 
formation in up to 8% of the patients (Ortigüela et al., 1987).  
 
1.2.3 Allografts 
Allografts have been successfully used as alternatives to autografts (Mackinnon et al., 
2001). However the implantation of fresh allografts can induce immune responses and 
immunosuppressive therapy may be needed for few years (Siemionow and Sonmez, 2007). 
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Patients on immunosuppressive therapy are susceptible to opportunistic infections. Allografts 
can be processed using various protocols to make them less immunogenic (Szynkaruk et al., 
2013).  
 
1.2.4 Decellularized nerves 
Isolated allograft nerves, processed with chemicals, result in decellularized nerves 
(Hudson, Liu, et al., 2004). Though the cellular components are lost, the extracellular matrix 
scaffolding within the nerve is retained (Hudson, Zawko, et al., 2004). This three-dimensional 
matrix is absent in other nerve guidance conduits. The chemical detergent technique to decellularized 
nerve is accepted clinically (Brooks et al., 2012). More recently, detergent-free techniques have also 
been used (Vasudevan et al., 2014). Detergent processed nerves were shown to be equivalent to 
autografts with respect to the nerve fiber count and the recovery of contractile force in the 
reinnervated muscles (Moore et al., 2011).  
Acellular grafts lack Schwann cells and they are not as successful as autografts when used to 
bridge larger gap distances (Nadim et al., 1990). Decellularized nerve grafts are also limited by 
disrupted endoneurial tubes and damaged basal lamina (Whitlock et al., 2009). The absence of 
Schwann cells make decellularized grafts lack the functional characteristics of normal peripheral 
nerves.  
 
1.2.5 Nerve transfer  
Nerve transfers involve the repair of an injured nerve by connecting the proximal end of 
another nerve or its fascicle to the distal aspect of the injured nerve. The function of the donor 
nerve is sacrificed so that the more important damaged nerve reinnervates more quickly (Narakas 
and Hentz, 1988). In this technique, unlike with autografts, the donor nerve would have 
reasonable amount of motor nerve fibers (Midha, 2004). Reinnervation of the injured nerve is 
done close to its target muscle for better outcome (Nath et al., 1997). The need for excision of a 
nerve graft from another site is not required as nerves in close proximity are used. However as 
the use of additional nerve grafts decrease functional outcome (Waikakul et al., 1999), the donor 
nerve has to be very close in proximity to the recipient nerve. This makes nerve transfer 
applicable only at certain anatomical sites as the area innervated by the donor nerve, loses 
function after the procedure.  
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1.3 Tissue repair scaffolds and scaffold materials  
Since each of the nerve-repair strategies discussed above has its own drawbacks, other 
novel nerve grafts have been constantly developed and investigated. Tissue repair scaffolds serve 
as supportive constructs to help with cell growth, migration and differentiation. They are 
fabricated using a wide selection of biomaterials, ranging from naturally occurring hydrogels to 
synthetic polymers. Agarose (Lee et al., 2009a), hyaluronic acid (Suri and Schmidt, 2010), 
alginate (Dhoot et al., 2004), hydroxylethyl methacrylate (Yu and Shoichet, 2005) and other 
hydrogel materials have been used to fabricate scaffolds in nerve tissue engineering.  Bioactive 
poly (L-lactic acid) conduits have been seeded with Schwann cells (Evans et al., 2002), while the 
same material has also been spun into aligned nanofibers (Yang et al., 2005). Tissue engineered 
scaffolds for peripheral nerve regeneration should have similar diameter as the nerve being 
repaired, be biodegradable, and easily implantable using currently available surgical techniques 
(Chalfoun et al., 2006). The scaffolds must also have appropriate surface chemistry favoring 
cellular attachment and have adequate mechanical properties (Hutmacher, 2001). Few common 
biomaterials used in the fabrication of scaffolds for peripheral nerve tissue engineering are 
briefly reviewed below.   
 
1.3.1 Alginate 
Alginate is a naturally occurring polysaccharide and has a promising role in the realm of 
tissue engineering. The proclivity of alginate in tissue engineering is attributed to the ability of 
including living cells within them. Other unique properties of alginate include an inert 
environment with adequate porosity allowing good diffusion rates of macromolecules and 
biodegradation of the system under normal physiological conditions (Gombotz and Wee, 1998).    
Alginate is commonly isolated from brown algae (kelp), found in the sea (Smidsrød and 
Skjak-Braek, 1990). A few of the sources of alginate include Laminaria hyperborea, 
Ascophyllum nodosum, and Macrocystis pyrifera. Alginate is a polysaccharide, composed of (1-
4) β-D-mannuronic acid (M) and α-L-guluronic acid (G). Both the M and G blocks are linked 
either randomly or as homopolymers (Johnson et al., 1997). The architecture of the blocks 
depends on the origin of the alginate. Having randomly arranged blocks, the molecular weight of 
alginate could vary and so would the viscosity, being dependent on the molecular weight (Kong 
et al., 2002). Alginate gels easily on binding of divalent cations to the G-units. This binding 
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causes a unique transition of the structure of alginate into the so-called ‘egg-box’ model 
(Sikorski et al., 2007).  
In general, alginates rich in G-blocks are stronger and more brittle than those with more 
M-blocks. The elastic modulus of alginate depends on the length of the chains and strength of the 
crosslinking (Draget et al., 1997). The concentration and type of the crosslinking agent also have 
a vital role. Other crosslinking agents, besides divalent calcium ions include adipic dihydrazide, 
methyl ester L-lysine, and PEG-diamines ( Lee et al., 2000). The use of divalent ions could lead 
to the loss of 60% of mechanical strength within 15 hours of exposure to the physiological 
environment. Thus the use of non-ionic crosslinking agents could regulate the mechanical 
properties and swelling indices of alginate (Lee, Bouhadir, et al., 2000). Increasing the content of 
G-blocks could increase the mechanical properties and porosity of alginate (Thu et al., 1996). 
While being crosslinked, alginate moves from the inner to the gelling zone and thus most of the 
gel at the center is ‘shifted’ (Draget et al., 1997). This leads to inhomogeneity in the gel and 
occurs when divalent ions are used in the crosslinking process. Controlled release of calcium (or 
other divalent ions) by using calcium carbonate or D-glucono-δ-lactone (GDL), solves this 
inhomogeneity issue (Kuo and Ma, 2001). Homogeneity of hydrogel is a major advantage for the 
encapsulation of cells.      
Certain sterilization techniques can compromise the viscosity of alginate. Autoclaving 
alginate results in the reduction of its viscosity by 64% (Vandenbossche and Remon, 1993). 
Similar losses in viscosity are also observed with ethylene oxide. γ-irradiation, on the hand 
induces free oxygen radical formation in alginate (Draget et al., 1997). Neural cells, in particular 
are very sensitive to free radicals or oxygen species (Raps et al., 1989). Membrane filtration does 
not confer a compromise to the viscosity and molecular weight (Vandenbossche and Remon, 
1993).  
Native or unmodified alginate is a poor substrate for the adhesion of mammalian cells. 
These cells have no receptors to adhere to alginate, making the growth of process from cells 
unfeasible, without the modification of alginate (Augst et al., 2006). Schwann cells cultured in 
2% low viscosity alginate resulted in reduction of neurite growth (Mosahebi et al., 2001). The 
culture of ovine intervertebral disc nucleus pulposes cells in 0.14% alginate beads, resulted in 
good viability but a poor cellular morphology.(Pattison et al., 2001). 
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Naturally occurring substances such as collagen (Sang et al., 2011), laminin (Yamada et 
al., 2010) and fibronectin (Mosahebi et al., 2003b) can however be added to enhance cellular 
adhesion. Laminin induces potent neurite outgrowth and promotes nerve regeneration over 
unusually long distances (Malinda and Kleinman, 1996). Laminin consists of three peptide 
chains, namely A, B1 and B2. The functional domains on the laminin chain define its interaction 
between various other cell surface receptors (Mecham, 1991a). Few laminin-based synthetic 
peptides have similar biological activity like laminin (Massias et al., 1993). The pentapeptide 
Tyr-Ile-Gly-Ser-Arg (YIGSR) and Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg (CDPGYIGSR) on the 
B1 chain of laminin are involved with cell adhesion and migration (Graf et al., 1987). The Ile-
Lys-Val-Ala-Va (IKVAV) sequence is found on the long arm of the A chain. This sequence is 
particularly known to aid the growth of neurites (Tashiro et al., 1989). The Arg-Gly-Asp (RGD) 
sequence in laminin is found in the short arm of the A chain (Tashiro et al., 1991). This sequence 
is pivotal in cellular attachment and is also the primary integrin-dependent cell-binding site on 
fibronectin. Fibronectin is a multimer protein in the extracellular matrix and exists as a soluble 
disulphide-linked dimer in plasma (Potts and Campbell, 1996). The fibronectin monomers 
consist of three different protein modules, namely F1, F2 and F3. In fibronectin, the RGD 
sequence of peptides is inserted in a loop between the two β-strands of module F3 (Bork et al., 
1996). Therefore modifying alginate with the addition of fibronectin, laminin, or cell adhesive 
peptides, is a mandate when culturing neural cells.  
 
1.3.2 Fibrin 
Fibrinogen, a glycoprotein is present in human blood plasma at a concentration of about 
2.5 mg/ml (Iwanaga et al., 2008). It is essential for hemostasis, angiogenesis, wound healing, and 
inflammation. Fibrinogen is soluble, but it forms a gel on interaction with the serine proteolytic 
enzyme thrombin. However the resulting fibrin filaments are not crosslinked until the addition of 
the transglutaminase, activated factor XIII (Kanaide and Shainoff, 1975). Fibrin is currently used 
clinically to plug bleeding vessels and as a replacement to sutures (Albala and Lawson, 2006). 
Using fibrin glue instead of sutures or staples enhances healing, minimizes scarring, and eases 
application. It has surgical applications in polymeric mesh fixation during inguinal hernia repair 
(Canonico et al., 2013), and skin graft adhesion (Branski et al., 2011). Fibrin sealant has also 
been successful at the coaptation of severed sciatic nerves in rats (Martins et al., 2005). 
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Few extracellular components interact with fibrin and can alter the structure and 
properties of fibrin clots. Fibronectin can covalently bind to fibrin (Kanaide and Shainoff, 1975). 
Fibrin also binds with hyaluronic acid and von Willebrand factor (Weisel, 2005). Fibrin has 
RGD sites and a pair of AGDV sites through which it can interact with integrins on Schwann 
cells (Chernousov and Carey, 2003). Binding of fibronectin with fibrin, would be an added 
advantage for Schwann cells as their proliferation is augmented by fibronectin (Baron-Van 
Evercooren et al., 1982).  
After injury to a peripheral nerve, fibrinogen from the plasma is activated into fibrin and 
is incorporated as an additional extracellular matrix protein of the nerve (Akassoglou et al., 
2000). Fibrin gel has been used as a vehicle to deliver nerve growth factor (Sakiyama-Elbert and 
Hubbell, 2000).  Fibrin containing Schwann cells has been used as a luminal filler to promote 
axonal regeneration (Galla et al., 2004). The addition of neurotrophins along with Schwann cells 
into fibrin has also been used for the regeneration of rat sciatic nerves (Ma et al., 2013). Inkjet 
printing has enabled layers of neural cells and fibrin to be stacked over each other to form a 3D 
structure (Xu et al., 2006). Fibrin is also an effective scaffold for cartilage and cardiovascular 
tissue engineering.  
 
1.3.3 Collagen  
There are many types of collagen and only a few of these form most of the extracellular 
matrix of peripheral nerves (Thomas and Olsson, 1984). Collagen plays an important role in the 
development and maintenance of the nerve (Hubert et al., 2009) and is present in all its three 
layers of connective tissue. Type-I, type-III and type-V collagens are the most common 
collagens in the nerve connective tissue. Type-IV collagen forms the basement membrane and it 
integrates laminin, perlacan, nidogen, and other ECM proteins into complex basement membrane 
aggregates (Hudson, Reeders, & Tryggvason, 1993). Collagens type-I and III provide 
mechanical support to the regenerating axons after nerve injury. 
Collagen provides good support for cell growth and it can enhance the differentiation of 
many cell types (Kleinman et al., 1981). Collagen conduits are used to bridge the gap between 
injured nerve stumps and can direct axonal sprouting from the proximal end of the nerve 
(Waitayawinyu et al., 2007). They are permeable, unlike other synthetic conduits and permit the 
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diffusion of nutrients between the conduit lumen and surrounding tissue. There are commercially 
available type-I collagen conduits available for clinical use–Neurawrap™, NeuroMatrix™, 
NeuroFlex™, and Neuragen®.  
Collagen gel, when used as an in vivo luminal filler in nerve conduit channels, increases 
axonal length and results in improved sensory function (Jin et al., 2013). Rolled sheets of 
collagen gels with cultured Schwann cells have been proposed as promising nerve repair 
conduits (Goto et al., 2010). 3D collagen scaffolds have been printed using a cryogenic direct-
plotting system, where the extruded collagen is immediately frozen to retain its structure (Kim et 
al., 2009).  
 
1.4 Incorporating cells in hydrogel scaffolds 
Neurite extension and migration within nerve scaffolds is augmented in the presence of 
neuroglia cells (Struzyna et al., 2014). Various living cells such as Schwann cells, olfactory 
ensheathing cells (Imaizumi et al., 2000), and neural stem cells (Guo and Dong, 2009) have been 
incorporated into scaffolds to support peripheral nerve regeneration. Living cells can be either 
seeded over scaffolds after their fabrication or incorporated during the scaffold fabrication 
process. 
Olfactory ensheathing cells are a type of macroglia exclusively located in the olfactory 
nerve and they produce neurotrophic factors to mediate neuronal survival and axonal elongation 
(Ramón-Cueto and Avila, 1998). In addition to enhancing axonal regeneration (Radtke et al., 
2009), they produce myelin (Devon and Doucette, 1992) and have better migratory potential to 
penetrate glial scars. Axonal regeneration was more pronounced in presence of olfactory 
ensheathing cells included into a laminin filled silicone tube (Verdu et al., 1999). Olfactory 
ensheathing cells have also been examined for spinal cord regeneration due their ability to 
promote growth of axons across the central and peripheral nervous system interface (Li et al., 
1997a), (Ramón-Cueto et al., 1998).   
 Macrophages have a pivotal role in clearing the myelin and cellular debris during 
Wallerian degeneration of distal nerve tissue, thereby facilitating axon regeneration through this 
tissue (Perry et al., 1987). There is in vivo evidence that macrophage recruitment could be 
important for the increase in nerve growth factor synthesis following nerve injury (Brown et al., 
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1991). Enhanced recruitment of macrophages can be achieved by efforts to improve the 
vascularization of peripheral nerve scaffolds (Griffin et al., 1993).  
Following peripheral nerve injury, activated migratory Schwann cells stimulate the 
elongation of axons (Torigoe et al., 1996). The guidance of axons is also influenced by the basal 
lamina of Schwann cells (Nguyen et al., 2002). They are the glial cells of the peripheral nervous 
system and produce neurotrophic factors, extracellular matrix, and adhesion proteins. Schwann 
cells of the distal nerve stump align themselves into 'bands of Büngner' (Fawcett and Keynes, 
1990) and the importance of this arrangement in promoting axonal growth is well documented 
(Taniuchi et al., 1986). During regeneration, Schwann cells migrate ahead of the extending 
axonal growth cones to guide axons (Torigoe et al., 1996). Regenerating axons do not elongate 
profoundly through acellular nerve grafts (Hall, 1986). Thus incorporation of Schwann cells into 
tissue-engineered scaffolds is beneficial.  
 
1.5 Fabrication of hydrogel scaffolds using dispensing techniques 
 By employing various fabrication techniques, hydrogels can be used to achieve the 
inclusion of Schwann cells into scaffolds. Among these techniques, rapid-prototyping (RP) 
methods have greater advantages in the fabrication of tissue-engineered scaffolds than the 
conventional techniques. RP enables greater pore inter-connectivity and higher porosity 
scaffolds, versatile control over the scaffold architecture, and discrete placement of different 
biomaterials. RP techniques such as fused-deposition modeling, selective laser sintering and 
stereolithography either require high temperatures or use resin in the fabrication of scaffolds, 
making them incompatible with most biomaterials. 3D printing and 3D bioplotting are examples 
of dispensing-based RP techniques that are compatible with the use of natural biomaterials and 
can be carried out under physiologically mild conditions, making incorporation of most cell 
types within scaffold biomaterials practical (Peltola et al., 2008). This approach allows 
incorporation of cells in the deeper layers of scaffolds, which is difficult to achieve by seeding 
live cells on pre-formed scaffolds. 
 3D bioplotting, as the name suggests, ‘plots’ scaffolds in three dimensions. 3D 
bioplotting is more accurate and requires less biomaterial than 3D inkjet printing (Pfister et al., 
2004). It is versatile, and can be used to dispense different materials including compatible 
polymers, resins and biopolymeric hydrogel solutions such as agar and gelatin (Glicklis et al., 
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2000). Structural rigidity of scaffolds is achieved by using thermoreversible hydrogels. Rat 
embryonic neurons, included in collagen and gelatin gels were printed into 3D scaffolds by 
maintaining the temperature of the gelling medium below the gelation temperature of the gels 
(Lee et al., 2009). In order to prevent collapse of the forming 3D structure prior to gelation of the 
hydrogel, dispensing can also be done into a liquid medium with approximately similar density 
as the plotting material, allowing buoyancy to counteract gravity (Landers, Pfister, et al., 2002). 
This enables better structural integrity of the scaffold as it is printed layer-by-layer. Bioplotting 
hydrogels into appropriate solutions (similar viscosity and density as the hydrogel) may also 
prevent excessive spreading of hydrogel on extrusion. Using a crosslinking solution (with the 
right physical and biological parameters) can also prevent the plotted scaffold from drying and 
could help with the fabrication of scaffolds with high cell viability.   
 
1.6 Research objectives  
The aim of this research is to characterize biomaterials suitable for 3D bioplotting of 
nerve repair scaffolds.  
Bioplotting, a freeform scaffold fabrication technique can be used for creating artificial 
tissue scaffolds containing living cells. However, simultaneous maintenance of scaffold 
structural integrity and cell viability is a challenging task. Schwann cells incorporated in the 
scaffolds must retain their viability, morphology, and also align themselves along the plotted 
strands for successful axonal guidance. Therefore a comparison of the suitability of alginate, 
collagen type-I, fibrin, and their mixtures for 3D bioprinting of hydrogel scaffolds containing 
Schwann cells is desired.  
Therefore the specific objectives of this research are as follows.   
 Fabricating a tissue engineered scaffold containing living Schwann cells for the repair of 
peripheral nerves. Bioplotting will be used to achieve scaffold fabrication, using a 
suitable crosslinker as the plotting solution.  
 Comparing Schwann cell viability in scaffolds strands that are printed into a crosslinking 
solution and printed in air.  
 Comparing Schwann cell viability and morphology in ‘printable’ hydrogels such as 
alginate, fibrin, and collagen type-I. The print fidelity of each hydrogel will be assessed 
by measuring scaffold strand width and interstrand spacing.  
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 Conducting a preliminary in vivo study using scaffolds with incorporated Schwann cells 
as nerve conduits in a rat sciatic nerve model. Functional outcome of the study will be 
assessed by behavioral studies and axonal regeneration will be assessed using 
immunohistochemistry techniques. 
 
1.7 Organization of the dissertation 
The dissertation is organized into 7 chapters. Besides this introduction, it includes five 
manuscripts, followed by the conclusions drawn from this research.  
A literature review on scaffold design and recent advances in biofabrication of scaffolds 
for use in peripheral nerve repair is presented in chapter 2.  The review focuses on the biological 
events following nerve injury, recent techniques used in the fabrication of biocompatible 
scaffolds, and strategic tissue scaffold designs for nerve injury repair. 
Chapters 3 and 4 focus on the fabrication of alginate-hyaluronic acid scaffolds containing 
Schwann cells. A novel technique, which helps with attaining good scaffold architecture, as well 
as viability of the contained Schwann cells is discussed. Chapter 4 illustrates the effect of a 
polycation on the physical properties of an alginate-hyaluronic acid scaffold.  
A preliminary in vivo experiment using alginate-hyaluronic acid scaffolds as a nerve 
conduit is presented in chapter 5. In chapter 6, the biological and fabrication of more 
biomaterials suitable for nerve regeneration are compared.  
Finally, chapter 7 presents the conclusions drawn from this research. This is followed by 
suggestions and recommendations for possible future research. 
 
1.8 Contributions of the primary investigator  
The manuscripts included in this thesis are co-authored; however it is the mutual 
understanding of all authors that Ajay Rajaram, as the first author, is the primary investigator of 
the research work. The contributions of other authors are greatly appreciated and acknowledged 
in this thesis. 
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CHAPTER 2 
STRATEGIC DESIGN AND RECENT FABRICATION TECHNIQUES FOR 
BIOENGINEERED TISSUE SCAFFOLDS TO IMPROVE PERIPHERAL NERVE 
REGENERATION* 
*This chapter has been published as "Rajaram A, Chen XB, Schreyer DJ. (2012) Strategic design 
and recent fabrication techniques for bioengineered tissue scaffolds to improve peripheral nerve 
regeneration. Tissue Engineering Part B: Reviews. 18(6): 454-467". According to the Copyright 
Agreement, "the authors retain the right to include the journal article, in full or in part, in a thesis 
or dissertation". 
 
2.1 Introduction 
 Peripheral nerve injuries can entail partial or complete transection of the nerve. At the 
cellular level, there can be transection of individual axons, possible neuronal death, and damage 
to the supporting Schwann cells and the myelin sheaths that they produce. Nerve injuries are 
described clinically using Seddon’s classification (Seddon, 1943). Some injuries allow the 
proximal and distal portions of the nerve to maintain continuity, allowing easy regrowth of 
transected axons, while others produce a gap that is difficult to bridge. One immediate goal of 
nerve tissue engineering is to create artificial, biomimetic scaffolds that can be used to bridge 
gaps and improve the ability of axons to regenerate back toward their peripheral innervation 
targets. This review focuses on the biological events that occur following nerve injury, recently 
developed techniques for fabrication of biocompatible scaffolds, and the strategic design of 
biomimetic tissue scaffolds for nerve injury repair.  
 
2.2 Peripheral nerve injury 
2.2.1 Incidence and etiology 
 Noble et al., (1998) compiled the incidence and prevalence rates of peripheral nerve 
injuries over the preceding decade. Their study illustrated that almost 46% of nerve injuries were 
due to road traffic incidents. The radial nerve, a nerve in the posterior compartment of the 
forearm, was injured most frequently. Nerve injuries also commonly occur as complications of 
regional anesthesia (Jeng et al., 2010). In a retrospective study by Taylor et al., (2008), the total 
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incidence of peripheral nerve injuries due to upper- or lower-limb trauma was 1.64%, with crush 
trauma having the highest rate of associated nerve injury. Grade-III ankle sprains, arising mostly 
from sporting activities, lead to a significant incidence of nerve injury to the nerves in the leg, 
causing prolonged rehabilitation time (Nitz et al., 1985). Compression neuropathies, such as 
carpel tunnel syndrome, can also induce chronic peripheral nerve injury. Moreover, some 
neuropathic disorders and tumors of the peripheral nerve require excision of part of the nerve. 
 
2.2.2 Events in nerve repair 
 Functional losses following peripheral nerve injuries arise primarily from interruption of 
the integrity of sensory, motor and autonomic axons. Crush or transection of the axon leads to 
reactive biological events in the neuronal cell bodies, the proximal segment of the injured nerve, 
the distal segment, and the peripheral innervation targets.  
 Axon transection separates distal lengths of axon from their parent cell bodies and results 
in a set of events in the distal peripheral nerve called Wallerian degeneration (Chaudhry et al., 
1992). The lengths of axon in the distal nerve that have been disconnected from the neuronal cell 
body degenerate, although the remaining proximal lengths of axon remain largely viable. 
Wallerian degeneration entails a set of histological changes in the distal nerve that include 
disintegration of severed axons and their myelin sheaths, and invasion of macrophages to clear 
degenerating cellular debris (Eto et al., 2003). Beirowski et al., (2005) showed that in mice, 
distal fragmentation of damaged nerves occurs within a short time frame of 40-44 hours.  
Resident Schwann cells also phagocytize the myelin debris (Goodrum et al., 1994); a 
phenomenon which has also been demonstrated in vitro (Fernandez-Valle et al., 1995). It is 
thought that timely clearance of degenerating debris is necessary in order for peripheral axons to 
regenerate properly (Chen and Bisby, 1993). Disintegration of disconnected axons also appears 
to require activation of the intrinsic ubiquitin-proteasome system which causes cytoskeletal 
disintegration (Fernyhough et al., 2005). The ubiquitin-proteasome cascade helps in the targeted 
degradation of proteins.  
Three to four days after injury, Schwann cells throughout the distal stump and at the tip 
of the proximal stump increase their rate of division (Hall, 2005) and elaborately rearrange 
themselves to form bands of Büngner, the vital guidance cue for the regenerating axon (Fawcett 
and Keynes, 1990). Schwann cells help to guide the regrowth of axons toward peripheral targets 
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to restore nerve function (Stoll and Müller, 2006). Son and Thompson, (1995) show that axonal 
regeneration is limited if Schwann cells are prevented from extending processes. Schwann cells 
also produce various neurotrophins, such as brain-derived neurotrophic factor (BDNF), 
neurotrophin (NT)-3, NT-4/5, and nerve growth factor (NGF) (Funakoshi et al., 1993), (Pellitteri 
et al., 2006) which can promote neuronal survival and/or axonal growth.  
In addition to events that occur near the damage site in peripheral nerves, axonal growth 
also depends on the type of neuron, age and  inherent regenerative capacity (Chierzi et al., 2005). 
Injured neurons must switch from a metabolic state that supports the function of mature, stable 
axons to one that supports the formation of a motile ‘growth cone’ expansion of the axon tip. 
Nerve injury results in the upregulation of various growth-associated proteins including 
transcription factors, signaling proteins, cytoskeletal proteins (Skene, 1989) and neurotrophic 
factors and their receptors. One example is the growth-associated protein-43 (GAP-43), a neuron 
specific protein which undergoes elevated expression during nerve regeneration (Skene and 
Willard, 1981). Partial depletion of GAP-43 in growth cones using antibodies (Shen et al., 2002) 
or antisense oligonucleotides (Aigner and Caroni, 1993) results in the reduction of F-actin, 
thereby impairing the motility function of growth cones. The synthesis of cytoskeletal proteins 
required for axonal reconstruction is also increased during regeneration (Fornaro et al., 2008). 
Lund et al., (2002) used in situ hybridization to show an increase in the β-actin mRNA levels, 
suggesting the importance of β-actin during axon regrowth.  
Important extrinsic growth factors include the neurotrophins, insulin-like growth factors 
(Fernyhough et al., 1993), hematopoietic cytokines such as leukemia inhibitory factor (McKay 
Hart et al., 2003) and interleukins (Bourde et al., 1996), fibroblast growth factor (Grothe and 
Nikkhah, 2001), and transforming growth factor (Chalazonitis et al., 1992). Extracellular matrix 
proteins such as laminin, fibronectin, collagen, matrix metalloproteinases and cell adhesion 
molecules also support and regulate nerve regeneration through specific interactions with the cell 
surfaces. These matrix components can also interact with the growth factors and promote axonal 
advancement. Addition of anti-laminin-2 antibodies to a culture of embryonic chick sensory 
neurons reduces the growth and total length of the neurites (Agius and Cochard, 1998). Thus, 
extracellular matrix factors, Schwann cells, and neurotrophins could potentially be exploited and 
integrated into scaffolds as biological factors that enhance regenerative success.  
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Newly sprouted axons enlarge and attain close-to-normal diameters with greater myelin 
sheath thickness as they proceed towards the distal end (Sanders, 1948). Quan and Bird, (1999) 
report that remyelination of injured peripheral nerves takes between 2–12 weeks, depending on 
the extent of the injury. Although the mechanism isn’t completely elucidated, it is known that 
many new axonal fibers grow and those that do not achieve close proximity to the target are 
pruned away. This specificity of reinnervation, produced by selective pruning of axon collaterals, 
could be influenced by relative levels of target-derived trophic support (Robinson and Madison, 
2004) and by molecular cues on Schwann cells (Martini et al., 1992).   
Fugleholm et al., (1994) assessed axonal growth in cats by using implanted electrodes 
and found the regenerative growth rate to be 3-4 mm/day after crushing a nerve, but lowered to 
2.5 mm/day in animals with sectioned nerves. Hoffman and Lasek, (1980) tagged rat cytoskeletal 
proteins with radioactive isotopes and found the actin in lesioned nerves to move distally at a rate 
of 2-5 mm/day. Buchthal and Kuhl, (1979) studied the sensory potential, evoked by stimuli to the 
digits, in patients treated for complete section of the median nerve. They found the rate of 
sensory axonal growth to be 1.5-2 mm/day. The rate of regeneration of peripheral axons is 
slower in humans than in rodents (Höke, 2006). Studies on in vivo nerve regeneration have 
usually been done on acute models of injury. However it is known that chronic denervation 
impedes the success of nerve regeneration (Fu and Gordon, 1997), suggesting that delayed 
treatment is likely to lead to a poorer clinical outcome.  Better understanding of the molecular 
mechanisms that impede or delay nerve regeneration would be beneficial in designing tissue 
repair scaffolds that are implanted at variable post-injury intervals to support axon regeneration. 
 
2.3 Fabrication of tissue scaffolds 
The emerging field of tissue engineering offers a new prospect for treatment strategies to 
foster regeneration of injured nerves and thereby promote restoration of sensory, motor and 
autonomic function. Tissue scaffolds are designed to serve as templates that support the 
regeneration of a tissue, organ or specific structure. These scaffolds can be fabricated using a 
wide selection of biomaterials, ranging from hydrogels to composite polymers. Rapid-
prototyping (RP) methods have advantages in the fabrication of tissue-engineered scaffolds over 
conventional techniques (Park et al., 2009). RP enables fabrication of scaffolds with greater pore 
inter-connectivity and higher porosity, versatile control over the scaffold architecture, and 
     17 
discrete placement of different biomaterials. However, RP techniques such as fused-deposition 
modeling, selective laser sintering, and stereolithography require either high temperatures or the 
use of resin in the fabrication of scaffolds, making them incompatible with most biomaterials. 
Three dimensional printing and three dimensional bioplotting are examples of dispensing-based 
RP techniques that are more compatible with natural biomaterials and could be carried out under 
physiologically mild conditions, making the incorporation of biological materials, even living 
cells, within scaffold biomaterials more practical (Peltola et al., 2008). Indeed, this approach can 
allow specific and directed incorporation of living cells anywhere within the scaffold, which 
would be difficult to achieve by seeding living cells onto the surfaces of pre-formed scaffolds. 
 
2.4 CAD-based tissue engineering 
Computer-aided design (CAD) is used extensively in the medical realm. Surgical 
reconstructions of large bone defects, especially cranial bones, are heavily dependent on CAD-
based reconstruction. Using CAD techniques and stereolithography with computed tomography 
guidance enables the fabrication of implants with good results in the reconstruction of complex 
skull defects (Saringer et al., 2002). Similarly, CAD techniques are useful in the fabrication of 
joint prostheses; for example, Jiankang et al., (2006) report the use of CAD techniques in 
fabricating and successfully implanting a customized tibial hemi-knee joint prosthesis in a 14-
year old girl. With increasing demands for biomimetic tissue scaffold designs, CAD techniques 
have been utilized in a number of recent fabrication methods (Table 2.1).  
 
2.4.1 Three dimensional bioplotting 
 As the name suggests, this technique ‘plots’ scaffolds in three dimensions, by which a  
viscous biomaterial is dispensed through a nozzle into a liquid medium, thereby retaining its 
shape without any temporary supportive structures. (Landers, Hübner, et al., 2002) describe a 
procedure for effective dispensing of hydrogels using the three dimensional bioplotting 
technique. In order to prevent the collapsing of the scaffold layers prior to gelation, the material 
is dispensed into a liquid medium with approximately the same density as the plotted material, 
allowing buoyancy to counteract gravity. Structural rigidity of thermoreversible hydrogels is 
achieved if the temperature of the receiving medium is below the gelation temperature of the 
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hydrogel. They also suggest the use of roughened surfaces as substrates for the first hydrogel 
layer dispensed; for example, the use of sandblasted metal plates as receiving surfaces. Lee et al., 
(2009) included rat embryonic (day 18) neurons in collagen and gelatin gels and then printed 
them into three dimensional scaffolds. Low pneumatic pressures (< 5 psi) and nebulization of the 
hydrogel crosslinker over each layer (once deposited) helped in achieving a good construct.  
 
Table 2.1. CAD-based fabrication techniques. 
 
(Pfister et al., 2004) compare three dimensional bioplotting with three dimensional 
printing, finding the former to be more accurate and requiring less quantity of the dispensed 
biomaterial. Three dimensional bioplotting is versatile and can be used to dispense different 
materials including polymers, resins, and biopolymeric hydrogel solutions such as agar and 
gelatin (Glicklis et al., 2000). Although plotting of most synthetic polymers using dispensing 
techniques could be challenging, polymeric formulations such as TEEX-29b (copolymer of L-
lactide and D,L-lactide dissolved in trichloroethylene and tetrachloroethane) and TEEX-31b 
(poly-l-lactide-caprolactone in trichloroethylene and tetrachloroethane) may be used due to their 
bioabsorbability, ability to be ink-jet printed, and cellular adhesion properties (Silva et al., 2007). 
However the ability to print patterns with an adequate and controlled density of living cells or 
Technique Description Advantages Reference 
3D bioplotting 
Viscous biomaterial 
plotted into a liquid with 
similar density 
3-D scaffolds, 
wide variety of 
materials could 
be dispensed 
(Pfister et 
al., 2004) 
Matrix-assisted 
pulsed-laser 
evaporation direct-
write 
Laser-guided dispensing 
of cells 
Better resolution 
and no 
dispensing 
nozzle 
(Wu et al., 
2003) 
Lased-induced 
forward transfer 
Laser activates a metal 
film that indirectly 
dispenses cells 
Less thermal 
damage to cells 
and better 
resolution 
(Ringeisen 
et al., 2010) 
Two-photon 
photopolymerization 
Infrared laser is focused 
onto a photosensitive 
biomaterial and 
polymerization is 
initiated by two-photon 
absorption 
High spatial 
resolution 
(Lee et al., 
2008) 
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biologically active molecules would be precluded by the use of organic solvents in the 
fabrication process.  
 
2.4.2. Laser-based fabrication techniques 
Laser-based techniques accurately deploy scaffold materials without the use of orifice- or 
nozzle-based dispensing. Thus, the process is immune to polymer adhesion and nozzle 
blockades. This approach also tolerates variations in the viscosity of the polymer or biomaterial 
solution. Laser-based methods are fast and can be more accurately controlled than most other 
techniques. Material deposition speeds are influenced by the laser pulse rate, stage control 
accuracy, and the nature of the receiving substrate.  
 
2.4.2.1 Two-photon polymerization 
In two-photon polymerization (2PP), a beam of infrared laser is focused onto a 
photosensitive biomaterial and polymerization is initiated by two-photon absorption. The 
greatest advantage of two-photon polymerization is that the absorption of photons from the laser 
by the material occurs only in the immediate vicinity of the focal point (Belfield et al., 2000). 
Using this approach, selective focusing of the laser within a three-dimensional space can bring 
about the fabrication of three dimensional structures with high spatial resolution (Sun and 
Kawata, 2004). Biodegradable triblock copolymer scaffolds of poly(ε-caprolactone-co-
trimethylenecarbonate)-b-poly(ethyleneglycol)-b-poly(ε-caprolactone-co-trimethylenecarbonate) 
have been made using 4,4’-bis(diethylamino)benzophenone as the photoinitiator with 4-μm 
resolution (Claeyssens et al., 2009). Two-photon polymerization of photosensitive materials are 
used to fabricate scaffolds with 100-nm resolution (Koroleva et al., 2010). (Lee et al., (2008) 
reported micro-patterning of a cell adhesive ligand (peptide RGDS) in poly(ethylene glycol-co-
peptide) diacrylate hydrogels using a two-photon polymerization technique. Human dermal 
fibroblasts seeded into these hydrogels underwent migration selectively into the RGDS-patterned 
regions of the hydrogels. Livnat et al., (2009) used multi-photon ablative laser to pattern 
fibrinogen hydrogel containing polyethylene glycol. Neurons could display motility within these 
constructs and their processes elongated in specific directions, aligning themselves to the 
patterns made on the gel. Thus, similar techniques might be used in peripheral nerve engineering 
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to guide migration of Schwann cells along bioadhesive pathways to form artificial bands of 
Büngner. Unfortunately, certain photoinitiators used in the polymerization technique can be 
cytotoxic. For example, acetophenone is toxic to cultured HepG2 cells at amounts greater than 
0.9 mg/mL (Liu and Bhatia, 2002). Thus, caution is needed during the initial selection of 
hydrogels, photoresists, or photoinitiators used in this technique.  
 
2.4.2.2. Laser-induced forward transfer (LIFT) 
Laser-induced forward transfer (Fig. 2.1) is a method that harnesses energy from 
nanosecond pulses of laser light and induces forward transfer of material. When used specifically 
to transfer living cells from cultures, this technique is known as biological laser printing (BioLP) 
(Ringeisen et al., 2010). BioLP is a nozzle-free technique that minimizes cellular damage and 
maintains cellular phenotype (Othon et al., 2008). No direct laser interaction with the substrate 
occurs and this technique is highly controllable and reproducible. Chen et al., (2006) show that 
bovine aortic endothelial cells are almost 100% viable with minimal effects from heat or shear 
stress when they are included during the BioLP process.  
Laser absorption onto any material causes an increase in temperature, leading to 
volatilization or even material expulsion. These material changes occur due to the thermo-
acoustical mechanisms initiated by photoabsorption of incident laser energy. BioLP utilizes an 
energy conversion layer consisting of a thin film of titanium oxide (TiO2), which absorbs most of 
the energy, thus preventing cellular damage. The cells to be transferred are maintained in a 
hydrogel material known as ‘bioink’, positioned immediately below the TiO2 layer. Upon laser 
irradiation, the TiO2 layer absorbs most of the energy and the heat induces displacement of cells 
from the bioink layer. Barron et al., (2004) exposed the TiO2 layer to laser beams with a 
wavelength of 266 nm and estimated that 99.9% of the incident laser energy was absorbed by the 
TiO2 absorption layer. Materials printed from the bioink by this technique are therefore exposed 
to substantially less heat (Barron et al., 2005). The absorption material must have a thickness 
greater than the penetration depth of the laser, but the transfer of heat through the laser 
absorption layer is independent of the absorption material thickness.  
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Figure 2.1 Laser-induced forward transfer (LIFT). 
 
Ringeisen et al., (2010) show good viability of olfactory ensheathing cells transferred 
onto a layer of Matrigel (a commercial mixture of extracellular matrix proteins) and success with 
the co-printing of olfactory ensheathing cells with rat cortical neurons. Othon et al., (2008) also 
demonstrate the capability of BioLP to print three-dimensional tissue scaffolds containing 
olfactory ensheathing cells, where the cells retain their phenotype and cell-cell interactions. This 
technique can transfer a volume of cells or other biomolecules at the pico-scale. Barron et al., 
(2005) demonstrate transfers as small as 0.5 pL and a droplet diameter as low as 30 μm. Dinca et 
al., (2011) used BioLP to dispense SH-SY5Y human neuroblastoma cells and show the ability of 
these cells to orient, migrate, and produce organized cellular arrangements on patterns generated 
on polyethyleneimine. Hopp et al., (2010) were unable to obtain 100% survival rates of 
transferred cells using BioLP (which they referred to as absorbing-film assisted LIFT). This may 
have been due to their use of femtosecond lasers instead of nanosecond lasers for the transfer of 
cells. Although ultra-short laser pulses reduce the thermal effects on the cells, they likely cause 
greater mechanical damage induced by the energetic plasma. 
 
2.4.2.3 Matrix-assisted pulsed-laser evaporation direct-write (MAPLE DW) 
The MAPLE DW technique (Wu et al., 2003) is a micro-printing tool that could help in 
the deposition of living cells within a scaffold biomaterial after fabrication of three-dimensional 
scaffold constructs. MAPLE DW is used to create micro-channels, micro-patterns, or networks 
within scaffolds. The micro-architectures created this way can be exploited for alignment of cells 
as most cells have a tendency to align themselves along certain cues, such as the presence of 
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extracellular matrix proteins (Zhu et al., 2010) or fields of electric current (Borgens, 1999) or 
also along the direction of small channels or patterns (Wilkinson et al., 2002). Harris et al., 
(2008) created channels of various depths in gelled agarose by altering the aperture of the laser. 
A431 human epithelial carcinoma cells and B35 neuroblast-like cells grown on these agarose 
scaffolds were subsequently found to align themselves in the direction of the micro-channels. 
Laser direct-write has also been used to pattern mouse embryonic stem cell distribution within 
gelatin (Raof et al., 2011); these cells maintained their stem cell pluripotency as evidenced by 
persistent expression of Oct-4. Creation of micro-channels in scaffolds for peripheral nerve 
regeneration therefore constitutes another method that could be used to produce alignment of 
Schwann cells in a pattern akin to the bands of Büngner. Indeed, sculpting patterns into scaffolds 
using the MAPLE DW technique could be of general value in the production of biomimetic 
cellular architecture to solve various problems in tissue engineering. 
 
2.5 Strategic design of scaffolds for nerve regeneration 
 The architecture, material, and even the fabrication process used to create a tissue 
engineering scaffold must be chosen with reference to, and with optimization for, the organ or 
tissue system being engineered. The unique structure and biological pathology of the peripheral 
nervous system imposes certain constraints. Biomimetic approaches that seek to duplicate or 
enhance the normally favorable aspects of peripheral nerve regeneration are likely to be 
successful (Winter and Schmidt, 2002). These include strategies to recreate endogenous healing 
mechanisms and appropriate mechanical environments within the engineered tissue (Willie et al., 
2010). Some strategies discussed here in the context of peripheral nerve regeneration might also 
prove applicable to other tissue engineering applications, such as the repair of central nervous 
system injuries. Some of the fabrication techniques discussed previously have already been 
implemented for the development of tissue engineering strategies in other organs. 
 
2.5.1 Incorporation of cells within scaffolds 
 Previous studies have reported the incorporation of a variety of living cell types into 
scaffolds to support peripheral nerve regeneration, including Schwann cells, olfactory 
ensheathing cells (Imaizumi et al., 2000) or neural stem cells (Guo and Dong, 2009). Living cells 
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can either be seeded into scaffolds upon completion of fabrication or incorporated during the 
scaffold manufacturing process, provided that harsh conditions are avoided. 
As described earlier, Schwann cells of the distal nerve stump align themselves into bands 
of Büngner (Fawcett and Keynes, 1990) and the importance of this arrangement in promoting 
axonal growth is well documented (Taniuchi et al., 1986). Since activated Schwann cells 
stimulate axon elongation (Torigoe et al., 1996) following peripheral nerve injury, the 
incorporation of Schwann cells into tissue-engineered scaffolds is likely to be a beneficial 
strategy. Hall, (1986) shows that regenerating axons do not elongate through acellular nerve 
grafts in which the migration of Schwann cells is impeded. (Li, Yan, et al., 2009) included 
Schwann cells and neural cells from the cortex of rats in composite scaffolds fabricated using 
alginate and gelatin. They found the cells to be viable for a week and also succeeded in seeding 
them in a gradient pattern. (Dewitt et al., 2009) incorporated Schwann cells into composite 
scaffolds of Matrigel® and collagen. Although Schwann cells have a spherical morphology in 
collagen type I scaffolds, the addition of Matrigel resulted in increased elongation of Schwann 
cell processes (by 4.2 times), better survival of the cells, and superior mechanical properties.  
 Olfactory ensheathing cells are a type of macroglia exclusively located in the olfactory 
nerve that can continuously produce neurotrophic factors to mediate neuronal survival and 
axonal elongation (Ramón-Cueto et al., 1998). In addition to enhancing axonal regeneration 
Radtke et al., (2009), they can produce myelin under certain circumstances (Devon and Doucette, 
1992) and have better migratory potential to penetrate glial scars. (Verdu et al., 1999) show that 
bridging proximal and distal nerve stumps with a laminin-filled silicone tube does not repair 
resected rat sciatic nerves, but axonal regeneration is observed when olfactory ensheathing cells 
are seeded along with laminin. Olfactory ensheathing cells have also been examined for their 
potential use to promote spinal cord regeneration due their ability to promote growth of axons 
across the central/peripheral nervous system interface (Ramón-Cueto et al., 1998), (Li et al., 
1997b).  
 Macrophages have a pivotal role in clearing the myelin and cellular debris during 
Wallerian degeneration of distal nerve tissue, thereby facilitating axon regeneration through this 
tissue (Perry et al., 1987). There is in vivo evidence that macrophage recruitment could be 
important for the increase in NGF synthesis seen following nerve injury (Brown et al., 1991). 
The peripheral nervous system receives ample infiltration by phagocytic cells (compared with 
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the central nervous system) and these are not usually included in peripheral nerve tissue 
engineering (Winter and Schmidt, 2002). However, enhanced recruitment of macrophages could 
be achieved by improving the vascularization of peripheral nerve scaffolds (Griffin et al., 1993).  
 Besides the addition of supportive cells, their orientation in scaffolds is also necessary for 
the maintenance of adequate function. Alignment of myocytes in muscle repair scaffolds is 
pivotal for triggering adequate and forceful contractions along a specific direction (Shimizu et 
al., 2009). Working with bone repair scaffolds, Kerschnitzki et al., (2011) concluded that 
formation of oriented collagen matrices in bone, and in turn better mechanical strength, requires 
specific alignment of osteoblasts. In peripheral nerve repair, Seggio et al., (2010) show that even 
in the absence of secondary guidance cues, a positive correlation exists between neurite 
outgrowth and orientation of the Schwann cells.  
Random seeding of cells into scaffolds may be insufficient to permit subtle tracking of 
cell migration and reproduce biologically important cell–cell interactions. Also, close 
confinement of cells at high density may result in regulation of specific cell signaling, resulting 
in reduced cell motility and proliferation. Advanced scaffold fabrication techniques such as 
laser-based deposition and bioprinting could help achieve precise cell-deposition in tissue 
scaffolds, applicable to peripheral nerve regeneration. Othon et al., (2008) showed that BioLP 
could be used to create three-dimensional hydrogel constructs with olfactory ensheathing cells 
confined in certain directions of the construct strands.  This oriented arrangement significantly 
promoted the migration of the cells in the hydrogel, reaching up to 400 μm from their original 
printed position within 24 hours. Bioprinting also helps regulate the spatial arrangement of cells 
during fabrication and it could be exploited for the simultaneous use of different materials, 
thereby enabling construction of composite scaffolds. This may not be possible by means of 
conventional methods. With the bioprinting method, Schuurman et al., (2011) fabricated 
composite scaffolds using cell-laden alginate and polycaprolactone. They showed that these 
composite scaffolds had better mechanical properties and also had the advantage of specific 
placement of various cell types in chosen patterns.    
 
2.5.2 Incorporation of bioactive peptides within scaffold materials 
Naturally occurring proteins, such as laminin (Yamada et al., 2010), fibronectin 
(Mosahebi et al., 2003a), and collagen (Sang et al., 2011) or peptides derived from them can be 
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added to scaffold materials to enhance cellular activities. Laminin induces potent neurite 
outgrowth and thus promotes nerve regeneration over long distances (Malinda and Kleinman, 
1996). Laminin is a heteromer composed of three protein subunits (A, B1 and B2) that each 
contain functional domains mediating interaction with various cell surface receptors (Mecham, 
1991b). Synthetic peptides based on laminin sequences have been shown to have biological 
activity (Massia et al., 1993). The peptides Tyr-Ile-Gly-Ser-Arg (YIGSR) and Cys-Asp-Pro-Gly-
Tyr-Ile-Gly-Ser-Arg (CDPGYIGSR) on the B1 chain of laminin are involved in cell adhesion 
and migration (Graf et al., 1987). YIGSR also prevents tumor metastasis (Witkowska et al., 
2004). The Ile-Lys-Val-Ala-Va (IKVAV) peptide sequence is found on the long arm of the A 
chain. This sequence is known to aid the growth of neurites (Tashiro et al., 1989).  The Arg-Gly-
Asp (RGD) sequence in laminin is found in the short arm of the A chain (Tashiro et al., 1991). 
This sequence is pivotal in cellular attachment through integrin receptors and is also a key 
sequence in another extracellular matrix protein, fibronectin.  
Fibronectin is also a multimeric protein that is present in the extracellular matrix, but also 
exists as a soluble disulphide-linked dimer in plasma (Potts and Campbell, 1996). The 
fibronectin monomers consist of three different domains (F1, F2 and F3). In fibronectin, the 
RGD peptide sequence is found in a loop between the two β-strands of the domain F3 (Bork et 
al., 1996). The RGD sequence is the primary integrin-dependent cell-binding site on fibronectin 
and is associated with cell adhesion.  
Specific peptide sequences from other extracellular matrix proteins also can aid in 
neuronal regeneration. (Kajiwara et al., 2005) investigated fetal hippocampal-derived 
neurospheres cultured on alginate gel. They observed adhesion and neurite outgrowth only when 
peptide sequences from the tumor necrosis factor receptor-1 protein were included in the 
alginate. The efficacy of peptides as growth-enhancing components depends on the expression of 
associated receptors in neural tissue (Meiners and Mercado, 2003; Yu and Shoichet, 2005).  
Itoh et al., (1999) show that axonal growth cones and Schwann cells have a high affinity 
towards laminin but may not recognize RGD sequences. However the YIGSR sequence of 
laminin enhances the adhesiveness of Schwann cells. Successful bridging of transected sciatic 
nerves was seen in rats when these transected nerves were grafted with silicone tubes filled with 
either Type I collagen fibers coated with laminin or the YIGSR sequence. The YIGSR sequence 
is thought to be recognized by receptors present on the growth cone or Schwann cell, promoting 
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their attachment and migration. Recently, laser transfer fabrication techniques have been 
employed in the transfer of peptide sequences to enhance cell adhesion. Spots of REDV peptide 
spots were transferred onto polyethylene terephthalate (PET) surfaces using LIFT. Human 
endothelial cells were layered over these peptide spots, and the patterned peptide was found to 
secure better attachment (Guillemot et al., 2008). Similarly, Zouani et al., (2009) deposited RGD 
peptides onto PET surfaces using the LIFT technique.   
 
2.5.3 Incorporation of neurotrophic factors  
 The neurotrophin family of signaling molecules, including NGF, BDNF, NT-3, and NT-
4/5, were initially thought to act primarily as regulators of neuronal survival. It is now clear that 
these neurotrophins are required for a variety of signaling functions in the regulation of 
development, maintenance, and function of the nervous system. They also control cellular 
differentiation, axonal growth, dendrite pruning and as well as the expression of various neural 
proteins and neurotransmitters (Huang and Reichardt, 2001). Since the acknowledgement of their 
diverse functions and mechanisms of action, many studies have incorporated the use of 
neurotrophins in peripheral nerve tissue engineering.  
 Artificial polysulfone nerve conduit tubes incorporating NGF and the extracellular matrix 
adhesion protein laminin promote successful nerve repair on par with autologous nerve implants 
(Yu and Bellamkonda, 2003). Synthetic polymeric scaffolds made of poly(lactide-co-glycolide) 
(PLGA) and coated with another neurotrophic protein, ciliary neurotrophic factor (CNTF), can 
repair 25-mm long canine tibial nerve defects (Shen et al., 2010). Lee et al., (2009) used 
copolymers of N-hydroxyl succinimidyl ester pyrrole and pyrrole and found that the addition of 
NGF to the copolymers favored neurite extension in neuron-like PC12 cells.  
 The use of hydrogels in the delivery of neurotrophins is advantageous due to their 
sustained-release behavior. Katz and Burdick, (2009) studied nerve conduits filled with the 
hydrogel poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) along with NGF-loaded 
poly(D,L-lactide-co-glycolide) microspheres. The result was more sustained release of NGF 
compared to conduits without microspheres. The effective role of hydrogels as carriers of 
microspheres or other delivery methods is the subject of continuing study (Piotrowicz and 
Shoichet, 2006). 
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Figure 2.2 Schematic of a scaffold with a neurotrophic factor gradient. 
 
Neurotrophins have also been encapsulated in microspheres made of various polymers 
such as chitosan, alginate, poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic acid), 
and poly(caprolactone) (Maysinger et al., 1996; Cao and Shoichet, 2003). Viral vectors have also 
been used to transfect genes that code for expression of neurotrophins (Berry et al., 2001). Non-
viral methods, such as transfection via lipoplexes, have also been used to introduce genetic 
material into cells (Whittlesey and Shea, 2006). Although a positive role of neurotrophins in 
peripheral nerve regeneration is widely recognized, a few studies indicate a potential ‘dark-side’ 
of these proteins and their receptors. Specifically, NT-4/5 may exacerbate free radical-induced 
necrosis of neurons both in vitro and in vivo. For example, neuronal death was accelerated upon 
addition of 10-100 ng/mL of NT-4/5 in neurons exposed to Fe2+ or L-buthionine-[S, R]-
sulfoximine (Won et al., 2000). Park et al., (1998) report similar effects with 100 ng/mL BDNF 
or NGF, with the damage dependent on the level of neurotrophins. Prolonged activation of TrkB, 
a receptor for BDNF, may have some detrimental consequences for neuronal survival (Kim et 
al., 2003). Thus, the optimal quantity and temporal profile of release of neurotrophins from the 
scaffold for efficient neuronal re-growth has yet to be established.  
Higher concentrations of neurotrophins could saturate cell surface receptors and lead to 
receptor down-regulation (Zigmond, 1981). Hence controlled and graduated concentrations of 
neurotrophins (Fig. 2.2) could help as guidance cues to the growth cones of axons (Gundersen 
and Barrett, 1979). The axons are guided to their targets by a combination of contact mediated 
and diffusible cues, either attractive or repulsive (Paves and Saarma, 1997). Cao and Shoichet, 
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(2001) devised a model to estimate the minimal and maximal effective concentration gradients of 
NGF in a custom-designed diffusion chamber. The minimum concentration required to guide 
neurite outgrowth from PC12 cells was assessed and found to be 133 ng/mL per mm. Dodla and 
Bellamkonda, (2008) describe a polysulfone nerve conduit filled with agarose hydrogel imbued 
with different concentrations of laminin and NGF. The concentration varied between 8 and 33 
µg/mL across four increasing step-gradients for laminin, and between 1.2 and 4.8 x 108 
liposomal microtubules (containing NGF)/mL across similar increasing step-gradients. 
Regenerating axons were observed in rats implanted with these anisotropic scaffolds but were 
absent in those implanted with scaffolds without gradients (isotropic). Moore et al., (2006) 
created a gradient hydrogel scaffold using a gradient maker with two inter-connected chambers; 
both were filled with p(HEMA) while only one chamber contained NGF. Spin bars blended both 
chambers as a peristaltic pump drove NGF-containing p(HEMA) into the p(HEMA) alone 
chamber, followed by extrusion of a hydrogel containing an increasing gradient of NGF. 
Although this system is capable of establishing a general global gradient, use of more recent 
fabrication techniques, such as bioplotting, permit better control over the configuration of 
gradients. Bioprinting techniques have been used to print spatially varying concentrations of 
neurotrophins by adjusting the printing resolution or number of dispensed droplets in a given 
area. Ilkhanizadeh et al., (2007) printed a gradient of increasing levels of ciliary neurotrophic 
factor (CNTF) on poly-acrylamide-based hydrogel and found a linear increase in the expression 
of the astrocyte marker glial fibrillary acidic protein (GFAP) by neural stem cells cultured on the 
surface.  
 
2.5.4 Electrical stimulation of scaffolds 
Artificially applied electrical stimulation can enhance peripheral nerve regeneration (Al-
Majed et al., 2000; Brushart et al., 2005; Geremia et al., 2007). A strategy of electrical 
stimulation might usefully be incorporated into the design of nerve repair scaffolds. Conductive 
polymers are a subgroup of materials with electronic and ionic conductivity, such as polyaniline, 
polypyrrole, polythiophene, and polyacetylene. The conductive property of these polymers is the 
result of certain dopant ions that help carry charges as electrical current (Ravichandran et al., 
2010). These polymers have been used in the synthesis of biosensors, bioactuators (Otero and 
Cortés, 2003) and neural prosthetics (Abidian et al., 2010). Polyaniline and poly(D,L-lactide) 
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electrospun at a ratio of 3:1 is electroconductive and cells seeded over these scaffolds are able to 
proliferate (McKeon et al., 2010).  
Weak electrical currents can accelerate axonal growth in vitro. For example, PC-12 cells 
grown on oxidized polypyrrole films show a two-fold increase in neurite outgrowth when 
subjected to weak electrical stimulation (Schmidt et al., 1997). The growth of axons in a constant 
electrical field in vitro is dependent on the charge of the substratum: axons move towards the 
cathode on negatively charged laminin surfaces and towards the anode on positively charged 
poly-L-lysine coated surfaces (Rajnicek et al., 1998).  
Induction of weak direct currents by implanting an electric circuit in rats enhances nerve 
regeneration and increases blood supply, as seen by an increased in number and diameter of the 
vasa nervorum (Mendonça et al., 2003) in association with enhanced axon regeneration. Thus, 
enhancement of vascular function (see below) may be a second beneficial outcome of electrical 
stimulation in nerve tissue engineering. 
  The beneficial effect of electrical stimulation on axon regeneration in vivo is greater if 
electrical stimulation is initiated rapidly following injury. Conversely, Yeh et al., (2010) found 
better myelination in rat sciatic nerves stimulated two weeks post-injury than those immediately 
treated with weak currents. However the effects of electrical stimulation are not always positive. 
In a study involving nerve regeneration through silicone rubber chambers, electrical stimulation 
hindered the growth of axons across the gap, although it accelerated the maturation of 
regenerating nerves if applied later (Lu et al., 2011). Moreover, McConnell et al., (2009) report 
local, deleterious, inflammatory changes in tissue surrounding chronically implanted electrodes, 
akin to late-onset neurodegenerative diseases. Hence, electrical stimulation could have both 
positive and negative effects, depending on pattern, strength, and/or timing. 
 
2.5.5 Addition of antioxidants 
 Oxidative stress can lead to apoptotic death of neurons (Greenlund et al., 1995). 
Apoptotic death of cholinergic neurons can be induced by NGF withdrawal, but this is prevented 
by high concentrations (50 mM) of antioxidant ascorbic acid (Kew and Sofroniew, 1997). 
Rogério et al., (2002) show that the antioxidant melatonin decreases neuronal death at doses of 
1-50 mg/kg in rats. Acetyl-L-carnitine (ALCAR) also has inherent antioxidant properties and is 
involved in mitochondrial aerobic glycolysis (Tesco et al., 1992). In a study by Wilson et al., 
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(2007) long-term systemic administration of ALCAR at 50 mg/kg/day increased nerve 
regeneration after injury and also resulted in greater myelination, improving the innervation of 
target organs. Carnosine (beta-alanyl-L-histidine), also an antioxidant, is protective for PC12 
cells subjected to excitotoxic stress caused by N-methyl-d-aspartate (NMDA) over-activation of 
glutamate receptors (Shen et al., 2007). Kilmartin et al., (2005) used NMR studies to evaluate 
the antioxidant properties of polyaniline and polypyrrole and observed that these substances 
could neutralize the damaging effects of 2,2-diphenyl-1-picrylhydrazyl (DPPH), a potent free 
radical. Thus, concurrent therapy with anti-oxidants, either administered systemically or included 
in nerve repair scaffolds, could be a useful strategy for tissue engineering targeting peripheral 
nerve repair. 
 
2.5.6 Enhancement of angiogenesis 
Proximity of a nutrient source is pivotal in the regeneration or growth of any cell or tissue 
type. In vivo, most cells lie within one to three cell widths of a capillary (Freitas Jr, 1999). 
Vascular compromise is prominent in most peripheral nerve injuries, including either the 
intrinsic or the extrinsic system of local blood vessels, or both. Incorporation of blood vessels 
within silicon conduits bridging nerve defects as long as 2-3 cm has been successful in rats 
(Kakinoki et al., 1997). ‘Feeder’ blood vessels within artificial nerve conduits also help axons 
regenerate for longer distances (Kakinoki et al., 1995). In current practice, a "vascularized nerve 
graft", or one that has viable blood supply, is often used to bridge a gap between transected nerve 
stumps. This attempt to maintain blood supply can also help sustain the Schwann cell population 
and decrease fibroblast infiltration (El-Barrany et al., 1999). Podhajsky and Myers, (1993) show 
an increase in the endothelial surface area of local small blood vessels one week following crush 
injury of the rat sciatic nerve, followed by a decrease at three weeks. However, the pattern was 
bimodal and endothelial surface area increased again six weeks after the injury. The initial 
increase was attributed to endothelial hypertrophy and the later increase to an increase in the 
number of blood vessels.  
The importance of coexisting capillary growth in promoting nerve regeneration has been 
emphasized by others (Goligorsky et al., 1999; Papavasiliou et al., 2010), but has received 
limited direct examination. In a study comparing angiogenesis following peripheral nerve injury, 
endoneurial capillaries were observed to sprout 5 mm distal to a nerve crush, repaired 
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transection, or ischemic injury, but not following a resection injury that created a gap (Nukada, 
1988). Neovascularization following nerve injury could be promoted by signals arising either as 
a consequence of nerve ischemia or as an inherent aspect of the regenerative process (Nukada 
and Dyck, 1984). Delayed vascularization in most tissue-engineered scaffolds is attributed to the 
absence of a preexisting vascular network. (Penkert et al., 1988) show that Schwann cells can 
survive for only one week in a graft without blood supply. 
Nitric oxide (NO) is a short-lived signaling molecule with multiple functions, including 
action as a potent modulator of vascular growth. Three isoforms of nitric oxide synthase (NOS) 
are expressed in peripheral nerve: neural NOS (nNOS) accumulating in growing axons of 
regenerating peripheral nerves, inducible NOS (iNOS) expressed in the invading macrophages, 
and endothelial NOS (eNOS) expressed by blood vessels in the vasa nervoram (González-
Hernández and Rustioni, 1999). Nerve regeneration and vascularization are delayed in 
endothelial nitric oxide synthase (eNOS) knockout mice when compared with wild-type mice 
(Keilhoff et al., 2002). Specific inhibition of eNOS using antisense oligodeoxynucleotides 
inhibits vascular remodeling (Goligorsky et al., 1999). Thus, incorporating a source of NO in 
scaffolds could be useful for peripheral nerve engineering to promote simultaneous 
establishment of new capillaries concurrent with axon regeneration 
 Vascular endothelial growth factor (VEGF) is also a fundamental regulator of both 
normal and abnormal angiogenesis (Ferrara, 1999). VEGF induces endothelial sprouting from 
sources of endothelial tissue embedded in collagen gel (Nicosia et al., 1994). Aizawa et al., 
(2010) show that the movement of endothelial cells can be guided in three dimensional hydrogels 
by concentration gradients of VEGF. This could thus be a promising strategy to enhance blood 
vessel growth into artificial tissue scaffolds. Hobson et al., (2000) assessed the effects of VEGF 
on the enhancement of vascularization and indirectly, on axonal regeneration in damaged nerve. 
VEGF and the synthetic extracellular matrix product Matrigel were enclosed in a nerve conduit 
and implanted into rats to bridge a sciatic nerve transection. After 180 days, the number of 
regenerated and myelinated axons was 78% greater when compared to control conduits lacking 
VEGF. In another study, Lee et al., (2010) constructed three dimensional scaffolds incorporating 
murine neural stem cells, collagen, and VEGF-releasing fibrin gel. The neural stem cells in 
closest proximity to the VEGF-releasing fibrin gel demonstrated better morphological changes as 
     32 
well as migratory responses. Thus, VEGF could have roles beyond angiogenesis in neural 
regeneration. 
 Novel delivery techniques for VEGF have also been explored. Kim and Kiick, (2010) 
propose the use of a specific polyethylene glycol-low molecular weight heparin (PEG-LMWH) 
hydrogel for carrying VEGF. VEGF was well contained in these hydrogels, due to its interaction 
with heparin, but was released for specific interaction with the VEGF receptor-2 (VEGFR-2). 
Similarly, Golub et al., (2010) demonstrated sustained release of VEGF from poly(lactic-co-
glycolic acid) (PLGA) nanoparticles, leading to enhanced blood vessel growth in mouse femoral 
artery ischemia models. Thus, patterned hydrogels could be synthesized to include bioactive 
substances enabling sustained delivery at specific sites. The benefits of vascular growth in 
parallel to nerve regeneration are apparent in many studies and bioengineering efforts to enhance 
peripheral nerve regeneration might include strategies that utilize factors and techniques that aid 
angiogenesis. With recent advances in fabrication techniques, supportive nerve cells and vascular 
endothelial cells could be printed simultaneously. Gaebel et al., (2011) showed that LIFT-based 
seeding of cells enhanced cell survival and modified their growth characteristics leading to 
increased blood vessel formation. Better formation of vessel-like structures was attributed to the 
precise control of arrangement of endothelial cells using the LIFT technique. Khalil and Sun, 
(2009) used a bioprinting fabrication system to print alginate scaffolds with a cell suspension of 
rat heart endothelial cells. Besides endothelial cells, VEGF has also been incorporated in fibrin 
gels and printed into collagen scaffolds using a bioprinter, to enable sustained release of the 
growth factor (Lee et al., 2010).  
 
2.6 Conclusions and future perspectives 
Much progress has been made since the earliest use of biomaterials as simple conduits in 
nerve regeneration. Techniques to incorporate neurotrophins, and control their release (Pfister et 
al., 2008) or produce gradients (Kapur and Shoichet, 2004) have been achieved. Material 
modification with peptide sequences have made scaffolds more adhesive, aiding in accelerated 
neural repair. Methods to promote adjunct angiogenesis (Hobson et al., 2000) are also of key 
interest. Recent advances in fabrication technology show great promise for even more 
sophisticated, precise and combinatorial strategies, thus generating synergy, in peripheral nerve 
repair. 
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 Though techniques to fabricate scaffolds with precise resolution are constantly explored 
or improved, methods to assess and visualize tissue growth or axonal regeneration in vivo are in 
need of improvement. Particularly useful would be the improvement of two photon imaging, 
diffusion tensor imaging, and ultrasound-based techniques to enable better monitoring of cell 
distribution during the process of nerve repair. Two-photon excitation can be used to visualize 
autofluorescent cells seeded onto three dimensional scaffolds (Schade et al., 2010), where most 
of the seeded cells remain close to the scaffold surface. This technique might also help assess 
cellular distribution in more sophisticated scaffolds where cell distribution is micropatterned 
during the fabrication process, as the scaffold need not be sectioned or manipulated for imaging. 
Diffusion tensor imaging (DTI) is a magnetic resonance-based technique that provides good 
imaging contrast and resolution to visualize nerve tracts (Le Bihan et al., 2001). This technique 
could be used to monitor nerve fiber content within scaffolds and along distal pathways toward 
peripheral targets. Hence, nerve regeneration in vivo could be assessed non-invasively. 
Ultrasound elasticity imaging (UEI) is a technique that images objects based on the induction of 
distortions, which reflect the elastic properties of the object being investigated (Svensson and 
Amiras, 2006). Speckle tracking has been used extensively in echocardiography (Blessberger 
and Binder, 2010), and was recently used to non-invasively assess the degradation of poly (1,8-
octanediol-co-citrate) scaffolds both in vivo and in vitro (Kim et al., 2008). Further development 
of these techniques is needed for more effective monitoring and analysis of nerve regeneration in 
vivo. 
The emerging fabrication techniques are themselves poised to be refined further for the 
advanced design of artificial scaffolds for applications such as peripheral nerve tissue 
engineering. Novel methods can be developed to simultaneously incorporate biomaterials such as 
growth factors or adhesive peptides along with living cells or other associated components that 
would closely mimic the natural environment and physiology of the tissue targeted for repair. 
Research aimed at understanding the cellular mechanisms of repair and further improving the 
engineering of biofabrication is likely to overcome some of the short-term impediments to the 
successful use of scaffolds to promote the improved repair of peripheral nerve injury. 
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CHAPTER 3 
BIOPLOTTING ALGINATE/HYALURONIC ACID HYDROGEL SCAFFOLDS WITH 
STRUCTURAL INTEGRITY AND PRESERVED SCHWANN CELL VIABILITY* 
*This chapter has been published as "Rajaram A, Schreyer D, Chen D. (2014) Bioplotting 
alginate/hyaluronic acid hydrogel scaffolds with structural integrity and preserved Schwann cell 
viability. 3D Printing and Additive Manufacturing. 1(4): 194-203". According to the Copyright 
Agreement, "the authors retain the right to include the journal article, in full or in part, in a thesis 
or dissertation". 
 
3.1 Introduction 
Bioplotting entails the extrusion of a biomaterial mixed with living cells to create tissue 
scaffolds for repairing or replacing damaged tissues or organs in tissue engineering (Chien et al., 
2013). Since the biomaterial is extruded layer-by-layer, a mechanically-stable structure can be 
created with interconnected pores favorable for the transport of nutrients. Due to its ability to 
continuously deposit material(s), an extrusion-based system can be used to fabricate tissue 
scaffolds with more complicated, yet repeatable, structures than conventional methods, such as 
solvent casting, freeze-drying, and leaching (Yeo and Kim, 2014). 
Compared to seeding cells over prefabricated scaffolds, incorporation of living cells 
during bioplotting allows better organization of the cellular components within scaffolds, 
including the uniformity in cell deposition and the ability to organize cell distributions to mimic 
the cellular organization of the intended tissue type (Nicodemus and Bryant, 2008). Bioplotting 
with living cells requires the use of a biomaterial that can be handled in aqueous and 
physiologically mild conditions. These materials are typically hydrogels made from natural 
carbohydrate or protein biopolymers and/or other synthetic polymers. Recently, the use of three 
dimensional (3D) biofabrication techniques has shown promise in the fabrication of hydrogel-
based structures laden with various types of cells. Fedorovich et al., (2008) used bioplotting to 
print various hydrogels with bone marrow stem cells. They showed good cell viability after the 
extrusion process and were also able to combine two distinct cell populations within a single 
scaffold. Schuurman et al., (2011) constructed scaffolds by alternate deposition of 
polycaprolactone fibers and alginate hydrogel containing C20A4 cells, a chondrocyte cell line. 
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These studies illustrate that by using 3D biofabrication techniques, scaffolds with spatial 
variations of more than one lineage of cells or different biomaterials could be fabricated.  
Hydrogels, either natural or synthetic, have been drawing considerable attention since 
they were first used to encapsulate pancreatic islet cells three decades ago (Lim and Sun, 1980). 
The high water content and tissue-like properties of most hydrogels make them ideal materials to 
encapsulate cells. Various hydrogels such as alginate, hyaluronic acid (HA), gelatin, type I 
collagen, fibrin, ExtracelTM hydrogel, methylcellulose, chitosan and polyethylene glycol have 
been used for 3D scaffold fabrication (Murphy et al., 2013). Alginate is a polysaccharide 
hydrogel, which is ionically crosslinked either in the presence of divalent ions such as calcium or 
barium, or by covalent methods (Christensena, 2011). Chemical crosslinking could compromise 
cell viability due to the harsh reaction conditions or the production of toxic intermediate 
products. However, ionic crosslinking of alginate using calcium chloride occurs under 
biocompatible conditions (Drury et al., 2004a; Khalil and Sun, 2009; Song et al., 2011) allowing 
for the incorporation of living cells during the fabrication process. 
HA is a glycosaminoglycan with repeating disaccharide units of glucuronic acid and N-
acetylglucosamine residues (Fraser et al., 1997a). It is a ubiquitous extracellular tissue matrix 
substance and has been known to promote peripheral nerve regeneration. HA prevents perineural 
scar formation during nerve repair and thereby improves peripheral nerve regeneration (Ozgenel, 
2003).  
Composite alginate/HA hydrogels have good mechanical properties, once crosslinked 
with calcium chloride (Wang et al., 2013). The interaction of HA with water significantly 
decreases the rate of weight loss of alginate/HA beads (Oerther et al., 1999), indicating improved 
stability. HA films containing vascular endothelial growth factor have been shown to improve 
electrophysiological and histological parameters in rats with transected sciatic nerves (Zor et al., 
2014).  
Inspired by these studies, the present study was aimed to fabricate alginate/HA hydrogels 
containing Schwann cells for use in peripheral nerve repair. Schwann cells provide haptotactic 
cues to axons and axonal outgrowth across a tissue lesion is accelerated in the presence of 
Schwann cells in peripheral nerve (Son and Thompson, 1995b). Mosahebi et al., (2002) have 
shown that including allogeneic Schwann cells in alginate-filled nerve repair conduits enhanced 
axonal regeneration without inducing an immune response. Schwann cell-filled nerve scaffolds 
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have also promoted functional recovery in rats with 2 cm long deficits in the median nerve (Sinis 
et al., 2005). 
The plotting of alginate and other composite hydrogels into scaffolds is a challenging 
task since many parameters, such as polymer concentration and viscosity, dispensing pressure, 
nozzle diameter, dispensing speed, and crosslinking, can affect the scaffold fabrication (Maher, 
Keatch, Donnelly, Mackay, et al., 2009; Nair et al., 2009). Ahn et al., (2012) used a nebulization 
technique and sprayed aerosolized calcium chloride solution over the surface of alginate struts 
dispensed on to a dry surface. However, dispensing low volumes of less concentrated alginate 
solution onto a dry surface can eventually lead to drying of the hydrogel, thereby compromising 
the viability of incorporated cells. If dispensing scaffold materials in an aqueous medium, the 
crosslinking medium itself also needs to be biocompatible to ensure cell viability. Strand 
buoyancy must also be controlled in order to prevent newly dispensed strands from floating in 
the medium during scaffold production (Pfister et al., 2004). Another important issue when 
bioplotting alginate is to ensure that the first layer of alginate adheres to the platform surface to 
prevent the collapse or disruption of the structure as more layers are stacked on it. The key 
factors for effective bioplotting include the enhancement of adhesion between the initial layer of 
hydrogel to the plotting surface and minimizing the density gradient between the hydrogel and 
the dispensing medium to achieve buoyancy compensation (Landers, Hübner, et al., 2002).  
In the present study, we addressed the preliminary requisites for bioplotting to enable 
effective fabrication of alginate-based scaffolds containing HA and living Schwann cells. We 
modified the platform for improved adhesion of the first scaffold layer and used a modified ionic 
crosslinking solution to improve structural control while retaining cell viability. We also 
characterized the bioplotting process in terms of scaffold strand width and interstrand spacing in 
single-layered scaffold patterns, and monitored the longer-term viability of incorporated cells 
after completion of scaffold fabrication.  
 
3.2 Materials and methods 
Alginate (sodium salt from brown algae), hyaluronic acid (HA) (sodium salt from 
Streptoccous equi), polyethyleneimine (PEI) (MW 750,000, 50% w/v in H2O), poly-l-lysine 
(PLL), glycerol, calcium chloride and polyvinyl alcohol (PVA) (MW 85,000-124,000) were 
purchased from Sigma Aldrich, Canada. PEI (MW 60,000, 50% w/v in H2O) was purchased 
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from Alfa Aesar, MA, USA. Calcein-AM and propidium iodide were purchased from Anaspec, 
CA, USA.  
 
3.2.1 Cell culture 
 RSC96 cells (ATTC, VA, USA), an immortalized rat Schwann cell line, were cultured using 
Dulbecco’s Modified Eagle’s Medium (DMEM) (Sigma, Oakville, ON, Canada) supplemented 
with 10% fetal bovine serum (HyClone, Logan, UT, USA) in a 37°C humidified environment 
containing 5% CO2. 
 Primary rat Schwann cells were isolated according to the D-valine selection method described by 
(Kaewkhaw et al., 2012). These were also maintained in DMEM with 10% fetal bovine serum in 
a 37°C humidified environment containing 5% CO2. Primary Schwann cells do not proliferate as 
quickly as RSC96 cells, thereby providing an advantage for culturing at longer time intervals. 
 
3.2.2 Polycationic surface for improved alginate/hyaluronate adhesion 
 Alginate has an anionic charge at physiological pH, and the polycation PEI has been used as a 
coating over microfluidic devices to enable surface adhesion of alginate (Johann and Renaud, 
2007). To promote adhesion of alginate to the plotting surface during the scaffold fabrication 
technique, tissue culture plates used as receiving platforms were coated with varying 
concentrations of sterile PEI (MW 60,000 and 750,000; in 10 mM phosphate buffered saline) and 
incubated overnight at 37°C. The plates were then washed with sterile water before use in 
scaffold fabrication.  
To assess the biocompatibility of PEI-coated surfaces, RSC96 cells were cultured in PEI-
coated 96-well plates for 12 hours. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) conversion assay was performed to confirm viability of the cells. MTT solution 
(5 mg/ml) was added to each well and the plate was incubated again for 5 hours. The medium 
was aspirated from all wells and dimethyl sulfoxide was added to solubilize the formazan 
reaction product. The absorbance of each well was measured at 560 nm using a micro-plate 
reader (Molecular Devices SpectraMax 340, California, USA). Control wells did not include 
PEI, but were coated with PLL, which is a commonly-used polycationic substrate for the culture 
of Schwann cells and dorsal root ganglion cells (Vleggeert-Lankamp et al., 2004). 
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3.2.3 Bioplotting of alginate/hyaluronate scaffolds 
Alginate/HA scaffolds were fabricated using a 3D-Bioplotter® (Envisiontec GmbH, 
Germany). The 3D-Bioplotter® is a pneumatic-based three-axis dispensing machine, which can 
be used to build scaffolds layer-by-layer. Scaffold designs were programed using CAD software 
to control the dispensing process. A solution containing alginate and HA (2.5% w/v alginate and 
0.25% w/v HA) was dispensed and plotted into the crosslinking solution using a steel-tip 
dispensing needle (EFD Nordson, Westlake, OH, USA) with an inner diameter of 100 µm. The 
plotting head was programmed to move the dispensing needle horizontally along the X or Y-axis 
at a speed of 4 mm/s and the pneumatic pressure driving extrusion of alginate/HA was set to 1.2 
bar (17.4 psi). In the present study, the scaffold was designed to have 16 layers, each having a 
height of approximately 125 µm, and an overall rectangular cuboid geometry of 10 × 3 × 2 mm 
(Fig. 3.1). Inter-strand spacing was set to 500 µm (measured between the centers of adjacent 
strands). The extrusion of biomaterial was continuous for each layer, but was interrupted and 
resumed for each subsequent layer. Strands dispensed in each layer were oriented perpendicular 
to those in the previous layer. The time elapsed for fabricating such a 3D scaffold was about 5 
minutes.  
The alginate/HA strands were plotted into a solution containing 100 mM calcium 
chloride, 25 mM HEPES buffer pH 7.4, 0.1% w/v PEI, and 0.95% w/v PVA. Low concentrations 
of PEI are known to increase the crosslinking of alginate (Devi et al., 2007) and PVA was 
included to prevent the strands from floating as they were being plotted. In some experiments 
PEI and/or PVA were omitted for comparison.  
 To create single–layered hydrogel patterns (strands with width of approximately 110 µm 
printed in a 10 x 10 mm pattern) alginate/HA biomaterial of the same composition were plotted 
using the 3D-Bioplotter® with the same dispensing needle and plotting parameters, but onto a 
PEI-coated surface in the absence of the crosslinking solution (i.e. in air). To prevent the 
hydrogel from drying and to enable crosslinking, a nebulized solution of 100 mM calcium 
chloride and 25 mM HEPES was sprayed over the hydrogel patterns as they were plotted. 
Afterward, they were immersed into the crosslinking solution (100 mM calcium chloride and 
0.95% PVA in 25 mM HEPES) to complete the crosslinking process at the end of 5, 15, or 30 
minutes. 
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Figure 3.1 a) Single layer of plotted hydrogel pattern. b) Multi-layered (16 layers) 3D hydrogel 
scaffold with dimensions of 10 x 3 x 2 mm. 
 
3.2.4 Evaluation of print fidelity 
The intended strand dimensions and interstrand spacing programmed on the software 
controlling the 3D-Bioplotter® machine were compared with their actual dimensions as measured 
post-fabrication. This gives a measure of the ‘print fidelity’ and depends on the properties of the 
hydrogel material and the accuracy of the dispensing technique (Chung et al., 2013). A single-
layer pattern (Fig. 3.1a) was bioplotted either into the crosslinking solution or in air and then 
imaged. The strand width and inter-strand distance of the patterns were measured on the images. 
The dispensing pressure was fixed, while the horizontal speed of needle was varied. The 
intended strand width was 100 µm (the needle internal diameter) and the interstrand spacing was 
set at 500 µm, measured between the mid-points of adjacent strands.  
 
3.2.5 Evaluation of cell survival after dispensing 
 We used a calcein-AM/propidium iodide microscopic assay (Anaspec, CA, USA) to study the 
effects of the scaffold fabrication technique on cell viability. A suspension of RSC96 cells or 
primary Schwann cells (5.2 x 105 cells/ml) in 50 µL of DMEM with 10% FBS was mixed with 
the alginate/HA solution and then plotted either into the crosslinking solution containing 100 
mM calcium chloride, 25 mM HEPES, 0.1% w/v PEI (0.05 % to 0.2% w/v), and PVA (0.95 % 
w/v) or into a similar solution containing glycerol (35% v/v) instead of PVA. The crosslinking 
solution was removed after 5 minutes and the single-layer scaffolds (strands with a width of 
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approximately 120 µm printed in a 10 x 10 mm pattern) were washed thrice with a solution of 
0.35 M sucrose and 4.2 mM HEPES, then maintained under standard culture conditions. Short 
term viability of RSC96 cells was assessed on single-layered patterns up to 30 min after 
crosslinking.; Viability of primary Schwann cells was assessed on days 0 (1 hour after 
dispensing) 3, 10, and 21. 
Cell viability was compared between strands plotted into the crosslinking solution and 
those plotted over a surface (in air) and nebulized with 100 mM calcium chloride and 25 mM 
HEPES. The patterns plotted in air were nebulized with 100 mM calcium chloride for 5, 15, or 
30 minutes and then immersed into the crosslinking solution for 5 minutes to complete the 
crosslinking process. The patterns plotted directly into the crosslinking solution were held in the 
solution for a comparable 5, 15, or 30 minutes before carrying out the viability assay. 
A solution of DMEM containing calcein-AM (8 μl/ml) and propidium iodide (15 μl/ml) 
was added to each sample and incubated for one hour at 37°C. Calcein-AM is converted into a 
fluorescent calcein dye by intracellular esterase activity to label live cells, while the staining of 
cells with propidium iodide (cell membrane impermeant) is specific to dead cells. The viability 
of cells was assessed by counting the live (green fluorescent) and dead (red fluorescent) cells 
(Fernandez et al., 2000) on images captured using a fluorescent microscope (Carl Zeiss Axiovert 
100). Images were randomly taken from each of three single-layered patterns in all test 
conditions (n = 10) and analyzed using ImageJ (National Institutes of Health, Bethesda, 
Maryland, USA). The viability was calculated as the percentage of live cells among the total 
number of live and dead cells detected. 
 
3.3 Data analysis 
The mean and standard error of the mean (SEM) of the data were calculated for each 
experimental test. Statistical significance was assessed by a one-way or two-way analysis of 
variance (ANOVA) followed by the Tukey’s ‘honestly significant difference’ (HSD) test using 
Graphpad Prism 5.0a (GraphPad Software, San Diego, CA, USA). Statistical significance was 
accepted at the level of p<0.05, estimated for comparisons between groups.  
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Figure 3.2 MTT assay comparing viability of RSC96 cells at the end of 12 hours when grown on 
surfaces coated with different concentrations of PEI [n = 8; * p<0.05; ns = not significant when 
compared with PLL].4 
 
3.4 Results 
  Dispensed strands of alginate/HA were well adhered to the surfaces coated with both the 
high and low molecular weight formulations of PEI. Firm attachment of alginate/HA onto the 
surface was ascertained as the plotted gel strands had a regular and reproducible shape and did 
not detach after fabrication or washing with phosphate buffered saline.  
The MTT assay was used to assess the viability of cells grown 12 hours on PEI-coated 
surfaces (Fig. 3.2). Culture plates coated with 0.1% PEI (MW 60,000) supported cell viability of 
greater than 90%, as compared to PLL control cultures. Coating the plates with higher 
concentrations of PEI (MW 60,000) appears to further reduce cell viability; and this effect 
becomes statistically significant when 2% PEI (MW 60,000) is used as compared to the control. 
Coating the plates with the high molecular weight form of PEI (MW 750,000) significantly 
reduce cell viability even at modest concentrations, 0.1 – 1%.  
Plotting alginate/HA into a simple calcium chloride/HEPES solution did not result in 
good scaffold architecture as the alginate/HA strands lifted up on the edges due to mismatched 
buoyancy between the hydrogel and calcium chloride solution. After preliminary trials in which 
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scaffolds were plotted into crosslinking medium containing varying concentrations of PVA 
(0.7% to 1.10% w/v) or glycerol (25% to 40% v/v), the concentrations of these components 
which most effectively eliminated the buoyancy effect were found to be 0.95% w/v and 35% v/v, 
respectively (data not shown). Inclusion of PEI in the crosslinking medium appeared to enhance 
gelation and intra-strand adherence of alginate/HA. A comparison of 3D scaffolds fabricated in 
the presence and absence of PVA and PEI is shown in Fig. 3.3. Having obtained good adhesion 
and structure with single-layer scaffolds, we fabricated 3D alginate/HA scaffolds with 
dimensions of 10 x 3 x 2 mm. With the presence of PEI and PVA in the calcium chloride 
crosslinking solution, a good 3D scaffold structure containing vertically interconnected pores 
was achieved (Fig. 3.4).  
 
 
Figure 3.3 10 x 6 x 2 mm alginate/HA scaffold fabricated a) without PVA and PEI in the 
crosslinking solution b) with 0.95% PVA and 0.1% PEI in the crosslinking solution.5 
 
Greater control of the geometry of dispensed biomaterial strands was obtained when 
plotting alginate/HA into a liquid crosslinking medium, as compared to plotting into air and 
crosslinking with a nebulized solution (Fig 3.5). When a single-layered pattern of alginate/HA 
was plotted in air at a dispensing speed of 4 mm/s, the resultant strand width was measured at 
462±5 µm (about 4.5 times of the needle internal diameter , 100 µm). Increasing the dispensing 
speed to 8 mm/s resulted in strand width of 353±7 µm. The significant difference between the 
strand width obtained and the diameter of the dispensing needle diameter is mainly caused by the 
initial spread of the alginate/HA solution when plotted over the platform surface. When using the 
same dispensing needle to plot strands into liquid crosslinking medium, we obtained strand 
widths of 108±2 µm and 53±4 µm at plotting speeds of 4 mm/s and 8 mm/s, respectively (Fig. 
3.6). These findings suggest that when plotting strands into liquid crosslinking medium, the 
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spread of the stands can be significantly reduced due to buoyancy and rapid gelation in liquid, 
and that the strand width is linearly dependent on the horizontal speed of the dispensing needled. 
Decreased strand width resulted in increased interstrand spacing (Fig. 3.6b) which ultimately 
leads to the creation of scaffolds with higher porosity.  
 
 
Figure 3.4 a) Alginate/HA scaffold in crosslinking solution immediately after being plotted. b) 
Scaffold imaged after being removed from the crosslinking medium (scale bar = 3 mm). c) 
Microscopic image of scaffold showing its porous structure (scale bar = 100 µm).6 
 
The calcein-AM/propidium iodide assay was used study the biocompatibility of 
crosslinking medium additives. RSC96 cell viability within alginate/HA 5 min after dispensing 
into a simple calcium chloride/HEPES crosslinking medium was 64% (Fig.3.7). No significant 
change was seen with the inclusion of 0.1% PEI in the solution. However, with the addition of 
0.95% PVA, the RSC96 cell viability increased significantly to 83%. Conversely, although 
scaffolds with good structural integrity were successfully plotted when using 35% v/v glycerol in 
the crosslinking medium (Maher, Keatch, Donnelly, and Paxton, 2009), the viability of RSC96 
cells was reduced drastically if glycerol was substituted for PVA (Fig. 3.7a). Because PEI is 
known to be toxic to cells, we studied whether soluble PEI in the crosslinking medium could be 
tolerated as well as surface-adsorbed PEI. We found no significant effect of PEI in the 
crosslinking solution at lower concentrations (0.05 - 0.1% w/v) but a nearly 25% reduction (68.8 
± 1.2) in cell viability when PEI was included at a concentration of 0.2% (Fig. 3.8). Thus we 
were able to show that a 0.1% concentration of PEI in the crosslinking solution that was effective 
in improving crosslinking of alginate/HA during fabrication of the scaffolds was safe for cell 
viability. 
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Figure 3.5 a) Alginate/HA strands plotted into crosslinking medium. b) Strands plotted in air. 
Measurements denote strand width. Intended dimensions: strand width of 100 µm and interstrand 
spacing of 500 µm, center to center. 7 
 
We studied the feasibility of plotting scaffolds in air by dispensing alginate/HA 
containing RSC96 cells onto a dry platform, nebulizing the strands for 5, 15 or 30 min with 
calcium chloride/HEPES solution, then flooding them with crosslinking solution for 5 minutes. 
The viability of RSC96 cells dispensed in air was measured at 61%, 5%, and 0% after being 
nebulized with calcium chloride solution for 5, 15 and 30 minutes, respectively (Fig. 3.9). By 
comparison, when plotting the strands directly into the crosslinking solution, RSC96 cell 
viability was 91%, 77%, and 68% after 5, 15 and 30 minutes, respectively. 
The long-term cell viability of primary rat Schwann cells was studied after using a 
dispensing process optimized for best results (Fig. 3.10). Primary Schwann cells were suspended 
in alginate/HA, then dispensed into complete crosslinking medium containing optimal 
concentrations of PVA and PEI. Exposure to this (non-physiological) solution was limited to 5 
minutes before the completed scaffolds were transferred to standard tissue culture conditions. 
We found that, similar to the RSC96 cells, primary Schwann cell viability is at a value of 92.3% 
immediately after plotting, then increases to 94.3% on Day 3, and is maintained at 83.2% at the 
end of 3 weeks. It should be noted that our cell measurements at multiday survival intervals were 
likely influenced not only by the death rate, but also by cell proliferation and disappearance of 
dead cells. 
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Figure 3.6 a) Strand width compared between patterns plotted in air or plotted into liquid 
medium at different plotting speeds. b) Interstrand space compared between patterns plotted in 
air or plotted into liquid medium at different plotting speeds [n = 5; *p < 0.001].8 
 
3.5 Discussion 
Alginate can be ionically crosslinked in a calcium chloride solution. Although high 
concentrations of calcium ions could damage cellular membranes, Cao et al., (2012) showed that 
encapsulating RSC96 cells in alginate resulted in better viability, even at relatively high 
concentrations of calcium. Best results are obtained when exposure to high calcium is brief. 
PEI interacts with alginate to enhance crosslinking (Devi et al., 2007). However, PEI was 
primarily used in this study to enhance alginate adhesion. The negative charges of alginate 
interact strongly with positively charged PEI coated surfaces. Chen et al., (2010) used a 0.5% 
w/v of PEI to coat the interior of microfluidic channels and found this to improve the adhesion of 
alginate to a glass surface. In the present study, we found that coating with the polycation PEI 
could stabilize the first layer of alginate-based materials. Also, we noticed that when single 
layers of alginate/HA containing cells were plotted on PEI-coated surface, the layers did not 
detach from the surface during the culture process. This also facilitates easier examination of the 
contained cells during imaging as the strands do not move while being imaged. On the uncoated 
surface, however, the plotted alginate/HA detached when it was immersed in the culture medium 
for few days.  
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Figure 3.7 a) RSC96 cell viability in alginate/HA strands 5 min after bioplotting into different 
crosslinking solutions [n = 10, *p < 0.0001; ns = not significant when compared with control]. b) 
RSC96 cells in alginate/HA strands stained with calcein-AM (green) and propidium iodide (red) 
after plotting into crosslinking solution containing 35% v/v glycerol. c) RSC96 cells in 
alginate/HA strands stained with calcein-AM (green) and propidium iodide (red) after plotting 
into crosslinking solution containing 0.95% w/v PVA (scale bar = 100 µm).9 
 
Because exposure to PEI may damage cells, we explored a range of PEI coating 
conditions and found that coating the surface with a low concentration of 0.5% PEI (Mw 60,000) 
was effective in promoting adhesion, yet displayed good biocompatibility. The addition of PEI to 
the crosslinking solution as subsequent scaffold layers are plotted is also helpful for promoting 
interstrand adhesion and stabilizing the 3D scaffold structure. We found that inclusion of soluble 
PEI at low concentrations of up to 0.1% in the crosslinking medium enabled good scaffold 
architecture, meanwhile having no negative effect on cell viability. Although the 3D scaffolds 
that we produced had good porosity on the Z-axis, the X- and Y-direction lacked the presence of 
obvious pores. This could be because the lower viscosity of the alginate/HA solution used to 
fabricate the scaffolds allowed a degree of collapse and compaction of the stacked layers. 
Therefore any strategy use of our Schwann cell-laden alginate/HA scaffolds for peripheral nerve 
     47 
repair may need to be supplemented with nerve conduit tubes with high porosity (Cerri et al., 
2014).  
 
Figure 3.8 RSC96 cell viability in alginate/HA strands after bioplotting into crosslinking 
solutions with different concentrations of PEI, assessed 5 min after crosslinking [n = 10, *p < 
0.0001; ns = not significant when compared with control] .10 
 
We investigated the inclusion of substances in the crosslinking medium to combat the 
disruptive effect of strand buoyancy during the fabrication process, and obtained good results 
with 0.95% PVA. At this concentration of PVA, the extruded strands of alginate/HA did not lift 
up or float towards the surface of the crosslinking solution. Although glycerol can also be used 
for the same purpose, PVA is a biomaterial that has previously been used with alginate in 
composite scaffolds to improve cell biocompatibility (Cho et al., 2005). We find that, compared 
to glycerol, which markedly reduces cell viability, the inclusion of 0.95% PVA in the 
crosslinking medium has a protective effect on the RSC96 cells. Future fabrication of larger 
scaffolds may be more time-consuming, and use of crosslinking solutions containing PVA could 
help maintain cell viability until completion of scaffold fabrication.  
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Figure 3.9 a) RSC96 cell viability in alginate/HA strands compared at various times after 
plotting in air with calcium chloride nebulization (then immersed in crosslinking solution) or 
directly into the crosslinking solution (100 mM CaCl2 and 0.95% PVA in 25 mM HEPES) [n = 
5; *p < 0.001]. RSC96 cells in strands plotted in (b) air (5 min, as above) and (c) into 
crosslinking solution and stained with calcein-AM (green) or propidium iodide (red) (scale 
bars=100 µm).11 
 
Over time in culture, it is seen that the viability of the primary rat Schwann cells reduces 
to 83.3% from an initial 92.5%. In our preparations, a few cells also escaped from the hydrogel 
patterns after a few days and attached to the bottom of the culture plate. This leads to decreased 
cells within the hydrogel pattern and affects assessment of viability over time. Further 
development of this technology may improve long-term cell survival. For example, alginate can 
be modified with cell adhesion peptides or other extracellular matrix proteins to enable better cell 
proliferation (Rowley et al., 1999). Schwann cells in standard cultures have a bipolar or trigonal 
morphology and assemble into sheets. However, when they are cultured in a simple alginate 
hydrogel they have a circular morphology and form clusters (Novikova et al., 2006), apparently 
due to the lack of adhesion to their surroundings. Biological cell adhesion, mediated for example 
by integrin receptors, can influence cell survival.  
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Figure 3.10 Primary rat Schwann cell viability in single-layered alginate/HA strands maintained 
post-fabrication for the indicated times in culture [n=10].12 
 
On comparing the plotting of scaffold patterns into the crosslinking medium with that in 
air, we found that the strand width and inter-strand space in patterns plotted into liquid medium 
conform much more closely to the programmed dimensions set on the dispensing machine. 
Apparently, strands with lower viscosity plotted in air spread and collapse before they can be 
stabilized with nebulized calcium chloride solution. Furthermore, the thin profile of strands (10 x 
10 mm pattern with strand-width of approximately 120 µm) printed on a dry surface caused them 
to dry over time, despite nebulization with calcium spray, leading to rapid cell death. In contrast 
low viscosity alginate/HA material plotted into the liquid crosslinking solution maintains 
hydration, and the buoyant forces exerted by the crosslinking solution prevent the hydrogel from 
spreading over the surface, allowing them to retain a cylindrical structure while ionic 
crosslinking takes place. Luo et al., (2013) have successfully printed scaffolds using high 
concentrations of alginate (16.7% w/v) in air and characterized the scaffolds, showing them to 
have a uniform and continuous porous structure. Plotting alginate or alginate-based hydrogels in 
air is feasible if the viscosity of the alginate solution is high. However highly viscous hydrogels 
require higher dispensing pressures and this can induce damage to cells suspended in the 
hydrogel solution (Kong et al., 2003).  Khalil and Sun, (2009) printed scaffolds using low 
viscosity of alginate (1.5% w/v) with suspended cells into a crosslinking solution and obtained 
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high cell viability. Our study also demonstrates that much higher cellular viability can be 
achieved by plotting low viscosity biomaterial strands directly into a crosslinking solution. 
It has been well established that the use of low dispensing pressure and extrusion needle-
tips with large internal diameter lead to increased cell viability during the plotting process 
(Chang et al., 2008). Li et al., (2010), have established a model to help estimate resulting cell 
damage based on shear and process-induced forces experienced by cells during the dispensing 
process. Mixing of the hydrogel and cell suspension until homogeneity is achieved helps in 
preserving the mechanical integrity of the scaffold and also increases the viability of the cells 
within them (Cohen et al., 2011). Thus, while our study examines chemical and geometric 
techniques to maintain cell viability immediately after plotting, control of other parameters such 
as speed and pressure while plotting the material also helps in improving cell viability. 
In early strategies of tissue engineering scaffold construction, living cells were randomly 
seeded over porous, biodegradable scaffolds. More recent and sophisticated strategies involve 
the creation of cell sheets, or the positioning of cell-laden ‘bio-ink” onto pre-formed artificial 
structures (Owens et al., 2013). These strategies may create scaffolds that more closely imitate 
the native biological architecture of tissues and organs (Mironov et al., 2009). In a more 
sophisticated example, cellular aggregates can be deposited over easily degradable hydrogels to 
eventually fuse and form a biomimetic construct (Marga, et al., 2012). The techniques described 
in the present study constitute yet another approach, whereby bioplotting might be used to 
position cells precisely and in defined geometry, for example to mimic oriented chains of 
Schwann cells (bands of Büngner) that appear to play an important guidance role in the 
regeneration of severed axons in injured peripheral nerve. The eventual goal of using 3D 
freeform fabrication techniques is to form precise and fully functional organs. Given their 
complexity and high cellular density, fabricating scalable organs could take several hours 
(Ozbolat and Yu, 2013). Therefore plotting cellular aggregates and scaffold material into 
biocompatible liquid solutions would enable better viability during an extended fabrication 
procedure. 
 
3.6 Conclusion 
Manufacturing scaffolds from biomaterials using advanced biofabrication techniques can 
be automated to lower material consumption and fabrication time. Though such advances have 
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been made in biofabrication techniques for tissue engineering purposes, the inclusion of cells in 
intricate scaffold designs is challenging, as many parameters need to be scrutinized. In this study, 
we have shown that bioplotting can be used for the dispensing of cell-laden alginate/HA 
hydrogel material with high cell viability. The use of PEI and PVA in the crosslinking medium 
helps stabilize scaffold structure and improve cell survival during the bioplotting process. 
Plotting scaffolds directly into the crosslinking solution resulted in better cell viability than 
plotting in air, and adjusting parameters such as speed and pressure helped in achieving the 
intended strand width and interstrand spacing. Evaluation of these above parameters is suggested 
in the plotting of any hydrogel material to enable a porous scaffold structure with good cell 
viability.  
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CHAPTER 4 
USE OF THE POLYCATION POLYETHYLENEIMINE TO IMPROVE THE PHYSICAL 
PROPERTIES OF ALGINATE–HYALURONIC ACID HYDROGEL DURING 
FABRICATION OF TISSUE REPAIR SCAFFOLDS* 
 
*This chapter has been published as Rajaram A, Schreyer DJ, Chen XB. (2015) Use of the 
polycation polyethyleneimine to improve the physical properties of alginate–hyaluronic acid 
hydrogel during fabrication of tissue repair scaffolds. Journal of Biomaterials Science, Polymer 
Edition. 9: 1-23". According to the Copyright Agreement, "the authors retain the right to include 
the journal article, in full or in part, in a thesis or dissertation". 
 
4.1 Introduction 
Alginate is a naturally occurring polysaccharide that has been used extensively as a 
biomaterial. Alginate solutions rapidly gel through ionic crosslinking upon exposure to divalent 
cations, allowing creation of complex structures by controlled dispensing into calcium chloride 
solutions (Stevens et al., 2004). Alginate gels have been used in drug delivery (Izawa et al., 
2013), delivery of growth factors (Freeman and Cohen, 2009), regeneration of cartilage (Wang, 
Yang, et al., 2012), cardiac remodelling (Landa et al., 2008), hepatic repair (Shteyer et al., 
2014), peripheral nerve regeneration (Sufan et al., 2001), and wound healing (Lee et al., 2009). 
However the low mechanical strength and rapid degradation characteristics of ionically 
crosslinked alginate gels are problematic when using this material to fabricate three-dimensional 
scaffolds for use in tissue repair.  
Hyaluronic acid (HA) is a glycosaminoglycan with repeating disaccharide units of 
glucuronic acid and N-acetylglucosamine residues (Fraser et al., 1997b). It has various 
applications in tissue engineering (Collins and Birkinshaw, 2013). HA has a positive influence 
on cell proliferation, attachment, and migration (Toole, 2004; Collins, 2014; Rizzo et al., 2014). 
HA prevents perineural scarring and results in enhanced peripheral nerve regeneration (Ozgenel, 
2003). Covalent crosslinking of hyaluronic acid improves its elastic moduli (Sahiner et al., 
2008). However, even in the absence of covalent crosslinking, nearly 50% of HA is retained in 
ionically crosslinked alginate at the end of 4 weeks (Lindenhayn et al., 1999). Composite 
alginate-HA hydrogels have improved mechanical properties upon ionic crosslinking with 
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calcium chloride, and the interaction of HA with water significantly decreases the rate of weight 
loss of alginate-HA gels (Oerther et al., 1999).  
The mechanical properties of alginate are correlated with the content of polyguluronate 
blocks in their chains (Smidsrød and Skjak-Braek, 1990). While covalent crosslinking has been 
performed to increase the mechanical properties of alginate with high guluronate content 
(Rowley et al., 1999), another plausible strategy is the formation of polyelectrolyte complexes. 
Polyelectrolyte complexes are formed due to electrostatic interactions between macromolecules 
of opposite charges (Manning, 1972). The hydrophilic nature, better mechanical properties, and 
low toxicity of polyelectrolyte complexes (Kotz, 1996), could make them suitable materials for 
tissue engineering. Alginate, being a polyanionic polysaccharide forms complexes with 
polycations like chitosan (Tapia et al., 2004) and PEI (Batyrbekov et al., 2011).  
Polyethyleneimine (PEI) is a synthetic aliphatic amine with a linear or branched primary 
structure. Although branched PEI is cytotoxic and has low hemocompatibility (Neu et al., 2005), 
linear PEI is less toxic and has been used as a vector in gene transfer (Fischer et al., 2002) and in 
plasmid DNA-based vaccines (Toke et al., 2010). As it is well established that the cytotoxicity of 
PEI is also molecular weight-dependent, PEI of low molecular weight is more favorable 
(Morimoto et al., 2003). Rat neuronal cell lines proliferate well on PEI-coated surfaces (Lakard 
et al., 2004) and PEI has also been electrospun into biocompatible scaffolds for potential use in 
tissue engineering and regenerative medicine (Khanam et al., 2007).   
On addition of PEI to alginate, strong ionic interactions result in a stable polymer with 
the linear alginate chains neutralizing the positive charges of PEI (Joung et al., 1987). Alginate 
beads coated with PEI tend to release entrapped drugs more slowly than uncoated beads (Halder 
et al., 2005). The extended release profile is dependent on the successful formation of a 
polyelectrolyte complex and the time of exposure to PEI (Setty et al., 2005). Coating alginate-
based scaffolds with polycations could particularly be useful when incorporating growth factors 
and extracellular matrix proteins.  
Formation of these complexes can delay the degradation of ionically crosslinked alginate 
even in the presence of calcium chelators (Smidsrød, 1973). The mechanical properties of 
alginate are also affected by PEI. For example, the Young’s (compressive) modulus of alginate 
was found to increase with addition of PEI (Mohamed and Salleh, 1982). While alginate-based 
polyelectrolyte complex microspheres have been extensively studied, tissue engineered scaffolds 
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have not been well characterized. In the present study, we compare the effects of PEI on the 
physical properties of alginate-HA gel scaffolds. 
 
4.2 Materials and methods 
Alginate (sodium salt from brown algae), calcium chloride dihydrate, hyaluronic acid 
(HA) (sodium salt from S. equi), polyvinyl alcohol (PVA) (MW 85,000-124,000), 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), bovine serum albumin (BSA), 
Bradford’s reagent, and Hoechst 33342 were purchased from Sigma Aldrich, Canada. PEI (linear 
with MW 60,000, 50% w/v in H2O) was purchased from Alfa Aesar, MA, USA. Propidium 
iodide was purchased from Anaspec, CA, USA. 
 
4.2.1 Preparation of the hydrogel and fabrication of the scaffolds 
Alginate (2.5% w/v) was mixed with hyaluronic acid (0.25% w/v) in 0.3 M sucrose with 
25 mM HEPES to prepare the hydrogel solution. The osmolality of the alginate solution was 
made physiological by using sucrose as a solvent. Solutions containing phosphate and 
monovalent ions were avoided as they affect the crosslinking of alginate (Drury et al., 2004a). 
Cuboid scaffolds with dimensions of 10 x 3 x 2 mm were fabricated from alginate-HA hydrogel 
using a 3D-Bioplotter (envisionTEC, Gladbeck, Germany). The composite hydrogel solution was 
plotted into the crosslinking solution using a steel-tip dispensing needle (EFD Nordson, 
Westlake, OH, USA) with an internal diameter of 100 µm. The crosslinking solution contained 
100 mM CaCl2, 0.95% PVA, and PEI (0.1%, 0.2% or 0.5% w/v). The addition of PVA increases 
the viscosity of the crosslinking solution and helps control buoyancy during the fabrication 
process. This prevents the printed hydrogel strands from floating in the crosslinking solution. 
PEI was added to the crosslinking solution as it augments ionic interactions during the 
crosslinking of alginate (Devi et al., 2007). PEI also binds ionically with HA forming a complex 
between its imino group and the carboxylic group (in HA) (Collins and Birkinshaw, 2008). 
Fabrication parameters such as speed, extrusion pressure, scaffold dimension and properties were 
similar to those used in our previous study and the time taken to fabricate the scaffold was 5 
minutes (Rajaram et al., 2014). As shown in our previous study, fabrication of multi-layered 
alginate-HA scaffolds was not feasible without addition of PEI to the crosslinking solution (100 
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mM calcium chloride and 0.95% w/v polyvinyl alcohol). Therefore assessment of the mechanical 
properties, swelling, and degradation rate of alginate-HA scaffolds, in the absence of PEI was 
not achieved. 
 
4.2.2 Mechanical properties 
The Young’s modulus of the alginate-HA scaffolds fabricated using crosslinking 
solutions containing either 0.1% or 0.5% PEI was assessed by compression testing, performed 
using a texture analyzer machine (Texture Technologies, MA, USA). The scaffolds underwent 
crosslinking for 30 minutes and their dimensions were measured using a digital caliper. They 
were subjected to compression until fracture, at a speed of 0.01 mm/second. The Young’s 
modulus of the scaffolds was determined from the slope of stress vs. strain plots, limited to the 
linear first 10% strain of the plot (Semmling et al., 2013). The average Young’s modulus was 
determined for both scaffold groups.  
 
4.2.3 Swelling index 
The swelling behavior of the alginate-HA scaffolds was studied in HEPES buffered 
saline (HBS), a physiological buffer. After fabrication of the scaffolds (crosslinked for 5 
minutes), they were immersed in 1.5 ml of the buffer and incubated at 37° C. Swelling was 
assessed at day 3, 7, 14, and 21. At the scheduled times, the scaffolds were blotted to remove 
excess buffer using Kimwipe® sheets and then weighed (Wt). The initial wet weight (W0) was 
obtained immediately after plotting the scaffolds in crosslinking solutions containing calcium 
chloride, HEPES, and either 0.1% or 0.5% PEI. The results are reported in a ratio, calculated 
using the formula, 
 
Swelling index = [(Wt-W0)/W0]*100….............................................................(4.1) 
 
where W0 is the initial wet weight of the scaffolds and the Wt is the wet weight of the scaffold (at 
time t). Three scaffolds were used for each group and the mean ± SEM is reported. 
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4.2.4 Degradation 
The degradation of scaffolds fabricated into crosslinking solutions containing either 0.1% 
or 0.5% PEI was studied in HBS. The scaffolds were kept in HBS at 37° C soon after fabrication 
(crosslinked for 5 minutes) and degradation was assessed at day 3, 7, 14, 21, and 28. To estimate 
degradative loss of the scaffolds, the dry weight (polymer content) was determined by weighing 
the scaffold at the mentioned time-points after complete drying (37°C for 48 h). The initial dry 
weight of was obtained by drying scaffolds immediately after fabrication. The percentage weight 
loss is determined by the formula, 
 
Percentage weight loss = [(W0-Wt)/W0]*100...................................................(4.2) 
 
where W0 is the initial weight of dry gel before degradation and Wt is the weight of dry gel at 
each time-point. Three samples were tested for each group and the mean ± SEM is reported. 
 
4.2.5 BSA release 
Bovine serum albumin (BSA) was mixed with the alginate-HA solution at a 
concentration of 1.66 mg/ml of hydrogel. Twenty µl of the resulting hydrogel was extruded into 
square-shaped patterns and crosslinked for 5 minutes. PEI at a concentration of 0.1% or 0.5% 
PEI at pH 7.4 was added to the crosslinking solution or omitted. BSA in the crosslinking 
solutions was estimated at the end of 5 minutes to ascertain the encapsulation efficiency of 
alginate-HA and further in vitro release was then performed in either 1 ml of 25 mM HEPES 
buffer (pH 7.4) or HEPES buffered saline (HBS). Sampling of the buffer solutions for released 
BSA was done at the end of 30 minutes, 1, 3, 6, 12, 24, 72, 96, and 120 hours. Five µl of each 
sample (n=5) was mixed with 250 µl of Bradford reagent (Sigma Aldrich, Canada) and light 
absorbance was measured at 595 nm using an ultraviolet-visual spectrophotometer (Spectra Max 
Plus 384, Molecular Devices, CA, USA). Fresh buffer of equal volume was added to replace the 
buffer removed for analysis each time to maintain a sink condition. The BSA released in the 
samples was estimated using a standard curve and the value is reported as the percentage of 
initially incorporated BSA released. 
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4.2.6 Cell viability 
Primary Schwann cells were isolated from rat sciatic nerves according to the method by 
Kaewkhaw et al. (2012). ATDC-5 cells were purchased from Sigma Aldrich (ON, Canada). 
ATDC5 cells, a chondrogenic cell line is derived from mouse teratocarcinoma and is promising 
to study chondrogenesis in vitro (Yao and Wang, 2013). To study the effect of the PEI on cell 
viability, a suspension of rat Schwann cells (1.6 x 106 cells/ml) was mixed with the alginate-HA 
solution and then plotted as strands into the crosslinking solution containing 100 mM CaCl2 with 
25 mM HEPES with or in the absence of PEI (0.1%, 0.2%, or 0.5% w/v). The same was done 
with the ATDC-5 cells. High concentrations of PEI, particularly high molecular weight PEI, are 
known to be toxic to mammalian cells (Florea et al., 2002). Lower molecular weight PEI was 
used in this study as the toxicity profile is reduced (Patnaik et al., 2006). The crosslinking 
solutions were removed after five minutes and the single-layer strands were washed thrice with 
Dulbecco’s modified Eagle’s medium. The viability of cells was assessed on day 1, 3, and 7 by 
counting the  total and dead cells after staining the cell-laden hydrogel strands with Hoechst 
33342 (2.5 μg/ml) and propidium iodide (25 μg/ml) (Fernandez et al., 2000). All the cells in the 
printed strands were counted on the single layered hydrogel patterns (n=3) from images taken 
using a fluorescent microscope (Carl Zeiss Axiovert 100). The images were analyzed using 
ImageJ (National Institutes of Health, Bethesda, Maryland, USA) and viability was calculated as 
the percentage of live cells among the total number cells counted. To enable easier and 
automated counting of nuclei, the z-project plugin on ImageJ was used to merge cells focused on 
multiple planes to a single projection (Cai et al., 2011).  
 
4.3 Data analysis 
The mean and standard error of the mean (SEM) of the data are reported for each 
experimental test. Statistical significance for the analysis of grouped data was assessed by two-
way analysis of variance (ANOVA) followed by Bonferroni’s correction for multiple 
comparisons. However for the compressive modulus measurements, Student’s t-test was used. 
GraphPad Prism 5.0a (GraphPad Software, San Diego, CA, USA) was used for data analysis. 
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4.4 Results 
The fabrication of 3-D scaffolds with good architecture was feasible in the presence of 
PEI (0.1% or greater) and PVA in the crosslinking solution. PEI increases the ionic crosslinking 
of alginate (Devi et al., 2007) in the presence of divalent calcium ions and PVA was included in 
the crosslinking solution to prevent the strands from floating while being plotted. The printed 3d 
alginate-HA scaffolds are shown in Fig. 4.1 and it is seen that the porosity along the vertical axis 
is maintained.  
 
 
Figure 4.1 Alginate-HA scaffold (scale bar = 3 mm).13 
 
To examine the effect of PEI on the mechanical properties of the scaffolds, the Young’s 
(compressive) modulus was estimated. The stress-strain curve of the scaffolds is shown in Fig. 
4.2a. The mean Young’s modulus of the scaffolds crosslinked with solution containing 0.1% PEI 
was 0.0014 MPa, while that of scaffolds crosslinked with solution containing 0.5% PEI was 
0.0016 MPa. Although the Young’s modulus trended higher with the use of 0.5% PEI, there was 
no statistically significant difference between the two groups (Fig. 4.2b).  
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Figure 4.2 a) Stress-strain curve of alginate-HA scaffolds crosslinked in the presence of 0.1% 
and 0.5% PEI b) Young’s moduli of the scaffolds [n=3].14  
 
The swelling index of the scaffolds fabricated in 0.1% PEI was 37.9 ± 8.6% on day 3, 
while that of scaffolds fabricated in 0.5% PEI was 85 ± 2.8% (Fig. 4.3a). By the end of day 21, 
these decreased to 16.3 ± 8% and 65.3 ± 1.4% respectively. Higher concentrations of PEI, 
(0.5%) led to an increase in scaffold swelling by 55.3% when compared to using 0.1% PEI. At 
the end of 3 weeks, the percentage dry weight loss of scaffolds fabricated in the presence of 
0.5% PEI was 12.1 ± 6.6%, while that for the 0.1% PEI was only 40.6 ± 3.1%. This increased to 
45.4 ± 5.2% and 65.6 ± 3.1%, at the end of a month (Fig. 4.3b). Therefore at the end of one 
month, scaffolds fabricated in 0.5% PEI retained 44.37% more mass than those fabricated in 
0.1% PEI.   
The percentage of BSA initially entrapped in the alginate-HA strands differed with the 
varying presence of PEI in the crosslinking solution (Fig. 4.4). It was 57 ± 0.8% in the absence 
of PEI. However in the presence of 0.1% or 0.5% PEI, it increased to 91 ± 0.6% and 92 ± 0.9% 
respectively. The release of BSA from the alginate-HA strands was estimated in HBS or 25 mM 
HEPES buffer (both at pH of 7.4) at various intervals. The presence of monovalent sodium ions 
in HBS leads to faster degradation of alginate, presumably through competition with calcium 
ions, eventually leading to greater BSA release. Although the presence of PEI during alginate-
HA crosslinking resulted in greater BSA content in the strands, the release of BSA in HBS was 
similar in all the groups by the end of 96 hours (Fig. 4.5a). In HEPES buffer, the release of BSA 
was not complete (Fig. 4.5b) and relatively more BSA (nearly 30%) was contained in strands 
that lacked PEI even the end of 96 hours.  
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Figure 4.3 (a) Swelling index in HEPES buffered saline (b) Percentage weight loss of scaffold in 
HEPES buffered saline at 37° C; [n=3, *p<0.005].15  
 
In the cell survival studies, viability of primary Schwann cells included in the alginate-
HA strands crosslinked in solutions with no PEI, 0.1%, 0.2%, and 0.5% PEI at day 1 was 78.3 ± 
1.2%, 78.9 ± 0.6%, 75.6 ± 1.7% and 66.7 ± 1.9% respectively. Similarly the viability for ATDC-
5 cells was 82.4 ± 0.7%, 78.2 ± 1.3%, 75.8 ± 3.9% and 72.4 ± 1.3% respectively. It was higher 
for the ATDC-5 cells as they are a cell line. At the end of 1 week, the viability of rat Schwann 
cells crosslinked in solutions with no PEI, 0.1%, 0.2%, and 0.5% PEI, reduced to 85.4 ± 1.7%, 
77.1 ± 1.5%, 60.5 ± 2.5%, and 68.8 ± 1.4% respectively. Similarly the viability of ATDC-5 cells 
at the end of 1 week was 74.1 ± 2.3%, 66.5 ± 1.2%, 58.7 ± 0.5%, and 58.1 ± 4.2% when 
alginate-HA strands were crosslinking in the absence of PEI, in 0.1%, 0.2, and 0.5% PEI 
respectively (Fig. 4.6). While the addition of 0.1% PEI had no significant effect on cell viability 
(both primary Schwann cells and ATDC-5 cells) at day 1 or at the end of 1 week, significant cell 
loss occurred with 0.2% PEI, and 0.5% PEI.  
 
4.5 Discussion 
For effective tissue regeneration using tissue repair scaffolds, porosity and the presence 
of interconnected spaces is of great importance (Malda et al., 2013). Porous alginate hydrogels 
provide a more favorable environment for cell proliferation due to enhanced mass transfer of 
nutrients and oxygen (Hwang et al., 2010). The process of dispensing alginate-HA strands in this 
study into a crosslinking solution containing calcium, PVA, and PEI resulted in scaffolds with 
interconnected pores. While the influence of PEI and PVA on the fabrication of the scaffold was 
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described in our previous article, here we show the addition advantages of PEI on the physical 
properties of the scaffold. 
 
Figure 4.4 Loading efficiency of BSA after crosslinking of alginate-HA strands for 5 min in 100 
mM CaCl2 with 25 mM HEPES (control), with added 0.1% or 0.5% PEI [n=5; *p<0.0001]. 16 
 
Increasing the concentration of PEI in the crosslinking solution decreases the percentage 
weight loss or degradation of plotted alginate-HA scaffolds. High molecular weight PEI more 
effectively delays the degradation of alginate gels when compared to PEI of lower molecular 
weight (Kong and Mooney, 2003). Therefore besides the absolute concentration of PEI, the 
molecular weight of PEI also affects gel degradation. PEI of higher molecular weight affects 
cells viability, similar to increasing concentrations of PEI. On comparing the viability of RSC96 
(rat Schwann cell line) cells cultured on surfaces coated with 0.1% PEI of molecular weight 
60,000 and 750,000, it was observed that viability declined with the use of PEI having larger 
molecular weight (Rajaram et al., 2014).  
Higher concentrations of PEI however, tend to induce greater swelling of alginate. This is 
a known feature of polyelectrolyte complexes and they can contain more that 85% of the solvent 
they are exposed to (Philipp et al., 1989). The interaction between alginate and PEI increases the 
mechanical strength of the scaffolds and the elastic modulus increases with higher concentrations 
of PEI (Kong and Mooney, 2003). Altering the mechanical properties of scaffolds can positively 
affect human chondrocyte behavior (Klein et al., 2010) and differentiate neural progenitor cells 
(Seidlits et al., 2010).  Addition of PEI to other hydrogel scaffolds composed of chitosan and 
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polyethylene oxide improves the attachment, proliferation, and activity of chondrocytes (Kuo 
and Ku, 2009). In our study however there was no significant increase in the mechanical 
properties, even when the PEI concentration was increased by five-fold. Alginate-HA is 
commonly used as an injectable scaffold for tissue regeneration (Dahlmann et al., 2013; Coates 
et al., 2013). Therefore the addition of PEI having varying molecular weights and/or 
concentration could be used to control the degradation and mechanical properties of alginate and 
alginate-HA scaffolds. 
 
 
 
Figure 4.5 Percentage of entrapped BSA release over time in a) HEPES buffered saline or b) 25 
mM HEPES.17  
 
Incorporating crosslinked HA in gelatin constructs led to an increase in its compressive 
modulus (Levett et al., 2014). Using varying concentrations and composition of alginate and HA 
enabled good control over the mechanophysical properties of injectable scaffolds (Dahlmann et 
al., 2013).  In this study, HA was not crosslinked to alginate. However besides its biological 
benefits, addition of HA to alginate, also increased the viscosity of the composite hydrogel and 
helped attain good strands during 3D plotting. Combining HA with alginate facilitates easier 
fabrication of 3D scaffolds using extrusion-based techniques (Wang et al., 2013).  
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Figure 4.6 Effects of PEI and time on a) primary rat Schwann cell and b) ATDC-5 cell viability 
within scaffolds [n=3]. Significant difference between each time point within a group (p<0.01) is 
indicated by *.18 
 
Although alginate is usually biologically inert, a few proteins, such as transforming 
growth factor beta, can be inactivated by alginate (Mumper et al., 1994). However BSA 
maintains its structure when incorporated in alginate (Zhao et al., 2009). BSA is initially 
contained within the alginate gel by entrapment as the gel forms. In our study we find that the 
inclusion of PEI during the crosslinking of alginate-HA strands increases the entrapment 
efficiency of BSA. Proteins encapsulated in alginate may be released either by diffusion or upon 
its degradation. The calcium-induced ionic crosslinking of alginate is sufficiently stable in 
aqueous media. The exchange of between Na+ and Ca2+ ions leads to subsequent degradation of 
alginate (Bajpai and Sharma, 2004). The high concentration of sodium ions in saline-based 
buffers displaces calcium ions in crosslinked alginate, leading to destabilization of the gels and 
release of BSA. Thus the release of BSA in alginate is greater in HEPES buffered saline 
compared with HEPES buffer alone. The addition of PEI appeared to slow the sustained release 
of BSA in our study as it improves the integrity of the gel and slows its degradation. In our study 
the larger surface area of the porous alginate-HA scaffolds, and/or the presence of HA may have 
accelerated the release of BSA. We also did not account for the loss of BSA to adsorption on to 
the surface of the tissue culture plate, in which the study was performed. The loss of BSA 
activity was also not assessed. However sustained release of proteins from alginate microbeads, 
even in the presence of PEI has been observed in various studies. Proteins like fibrinogen, 
interleukins, insulin, nerve growth factor, fibroblast growth factor, etc., have been incorporated 
into alginate matrices (Gombotz and Wee, 1998). Therefore the addition of low concentrations of 
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low molecular weight PEI during fabrication of the alginate scaffolds would likely enable better 
encapsulation of most of these proteins, providing a better in vivo delivery system. 
Advanced tissue engineering applications are being developed which allow the 
entrapment of living cells within the scaffold material during the fabrication process, provided 
that all steps of scaffold fabrication can be carried out under physiologically mild conditions. 
Alginate and alginate-HA gels are particularly suitable for the inclusion of cells; as gel formation 
can be accomplished by ionic crosslinking or polyelectrolyte complex formation. Human stem 
cells derived from adipose tissue have enhanced cell adhesion and proliferation when cultured in 
alginate-HA (Son et al., 2013). Schwann cells proliferate more on surfaces coated with PEI 
(Vleggeert-Lankamp et al., 2004). As guidance of regenerating axons is greatly influenced by 
Schwann cells, their role in nerve repair scaffolds is pivotal (Nguyen et al., 2002). Coating 
polymeric surfaces with alginate/PEI also improves the attachment, proliferation, and activity of 
chondrocytes (Zhu et al., 2004). Though most cell types are compatible with alginate-HA, 
primary rat Schwann cells and a chondrogenic cell line (ATDC-5) were studied here due to the 
positive effects of PEI on them. Our findings show that viability of encapsulated Schwann cells 
and ATDC-5 can be adequately maintained for long periods following the formation of 
polyelectrolyte complexes using PEI. Indeed, the known toxic effects of PEI may be mitigated 
precisely because the PEI is bound into a polyelectrolyte complex. Nevertheless, the best cell 
survival results appear to be dependent on PEI concentration, and any application involving 
living cells will have to find the optimal balance between the advantageous physical 
improvements resulting from the use of PEI, and the possible decrease in cell survival that may 
occur at higher concentrations. 
 
4.6 Conclusion 
We have shown that the physical properties of alginate-HA tissue repair scaffolds can be 
tuned by the addition of PEI during the crosslinking process. Many such scaffolds are also being 
designed to act as vehicles of growth factor delivery to the site of tissue repair. The addition of 
PEI to alginate-based scaffolds could result in more efficient entrapment and prolonged delivery 
of such growth factors. While adjusting the physical parameters of polyanionic biomaterials by 
the addition of PEI could lead to harsher environments for cells, we have shown that at low 
concentrations of PEI, the viability of Schwann cells is not severely affected. From this study, it 
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is inferred that low molecular weight PEI at concentrations of up to 0.1% have no detrimental 
effect on cells and its use can significantly improve the entrapment of protein within scaffolds. 
Therefore the strategy of using PEI in alginate-based biomaterials will likely be beneficial in the 
future design of tissue repair scaffolds, especially those that require encapsulation of growth 
factors and/or living cells for regenerative applications. 
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CHAPTER 5 
PRELIMINARY STUDY ON THE USE OF 3D-PRINTED ALGINATE-HYALURONIC ACID 
NERVE CONDUITS FOR THE REGENERATION OF RAT SCIATIC NERVE IN VIVO 
 
5.1 Introduction  
Clinical use of nerve conduits is currently limited to 30mm defects (Battiston et al., 
2009). Most clinically approved nerve conduits have a basic hollow cylindrical design made 
using biomaterials such as collagen, polycaprolactone, polyglycolate, and polyvinyl alcohol 
(Pabari et al., 2014). Strategies to improve the design of single-lumen nerve conduits include 
improving conduit permeability (de Ruiter et al., 2009), filling the conduit with hydrogels 
(Belkas et al., 2005), inclusion of Schwann cells (Rodríguez et al., 2000), and addition of 
neurotrophic factors (Midha et al., 2003). Inclusion of Schwann cells have additional advantages 
like the production of neurotrophic factors and the alignment of axons.  
Schwann cells in nerve conduits increase the expression of growth factors, axonal 
regeneration, and motor function (Jesuraj et al., 2014). Nerve repair using acellular nerve 
conduits is limited due to the senescence of Schwann cells that migrate into the conduit (Saheb-
Al-Zamani et al., 2013). Segmental nerve defects have shown better regeneration by including 
Schwann cells into repair conduits (Berrocal et al., 2013). Aligned Schwann cells have the 
ability to direct axonal growth (Thompson and Buettner, 2006). Axons are directed along 
oriented Schwann cell in monolayer cultures even in the absence of other directional cues 
(Seggio et al., 2010). Schwann cells can also be aligned within a three dimensional hydrogel 
matrix (Georgiou et al., 2013).  
Advances in fabrication techniques have resulted in better nerve scaffold designs. Three 
dimensional (3D) bioprinting is compatible with natural biomaterials and can be carried out 
under physiologically mild conditions (Peltola et al., 2008). It enables cell deposition within 
biomaterials at very high densities (Marga et al., 2012). This approach can allow specific and 
directed incorporation of living cells anywhere within the scaffold, which would be difficult to 
achieve otherwise. Improved porosity and permeability, precise control over scaffold geometry, 
and cell alignment within the scaffold are feasible using layer-by-layer rapid prototyping 
techniques. Cells are capable of aligning themselves along the direction of hydrogel strands, 
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printed using these techniques (Barry et al., 2009). Neurons cultured in vitro can align 
themselves along patterns of 3D-printed collagen (Roth et al., 2004).  
Alginate, a naturally derived polysaccharide biomaterial, has been used as a Schwann cell 
matrix (Mosahebi et al., 2001). Alginate is inert and does not evoke an immune response in the 
body (Wee et al., 1995). Alginate-based hydrogels have been micropattered to culture cortical 
neurons in three dimensional (3D) environments (Kunze et al., 2011). Alginate also enables 
Schwann cell migration and promotes axonal regeneration in vivo (Hashimoto et al., 2002). 
Alginate crosslinks rapidly with calcium chloride and this makes it an appropriate material  to 
fabricate scaffolds while using free-form techniques (Song et al., 2011) 
Hyaluronic acid has been used to treat neuromas clinically (Monacelli et al.), and its 
inclusion in nerve scaffolds, alleviates neuroma formation in resected peripheral nerves. 
Hyaluronic acid also has good hydrating properties and lowers the formation of scars. During 
peripheral nerve repair, it prevents perineural scar formation and enhances regeneration 
(Ozgenel, 2003). Alginate-based composite hydrogels with hyaluronic acid (HA), enable easier 
gel-formation and induce good healing (Oerther et al., 2000). The hydrating properties of HA 
makes it a good carrier of bioactive proteins. Combining alginate with HA results in the HA 
being trapped in the gel structure as calcium ions crosslink the alginate. Addition of fibronectin 
to alginate improves the viability of Schwann cells and also enhances axonal regeneration 
(Mosahebi et al., 2003a). In this study we propose that 3D printed alginate-HA scaffolds, 
augmented with fibronectin can be used as effective nerve repair conduits in a rat sciatic nerve 
model. We also include labelled Schwann cells in the scaffolds for in vivo tracking. 
 
5.2 Methods 
5.2.1 Isolation and staining of primary rat Schwann cells 
Primary rat Schwann cells were isolated from the sciatic nerves of Sprague-Dawley rats 
according to the method described by Kaewkhaw et al. (2012). The sciatic nerve was isolated 
and the epineurium was stripped. The nerve was then cut into smaller 2 mm fragments and 
digested with collagenase for 1 hour. The resulting cell suspension was filtered and cultured in 
Dulbecco’s Modified Eagle’s Medium (DMEM) containing forskolin, N2 supplement, and 
bovine pituitary extract. D-valine was used in the DMEM preparation as it suppresses fibroblast 
growth. 
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The primary Schwann cells were maintained in culture until 5 passages. They were 
stained for S100 to ascertain the purity of the culture. They were then labelled with PKH26, a 
cell membrane-labelling fluorophore, according to the manufacturer’s instructions (Sigma 
Aldrich, ON, Canada). The PKH26-labelled Schwann cells were maintained in culture in vitro to 
assess for the stability of the fluorescent marker. The labelled cells were seeded on a tissue 
culture plate (cell density of 2.8 x 105/ml) and cultured in primary rat Schwann cell culture 
medium (Kaewkhaw et al., 2012) for a month. Images were acquired using a fluorescent 
microscope (Carl Zeiss Axio Imager A1) and the mean gray value of random cells (n=25) from 
three separate cultures was assessed.  
 
 
 
 
Figure 5.1 a) Alginate-hyaluronic acid scaffold b) Scaffold placed over collagen type-I sheet.19 
 
5.2.2 Fabrication of the scaffold conduit 
The scaffold used in the study was fabricated using a 3D-Bioplotter (Envisiontec GmbH, 
Germany). A composite hydrogel solution comprising of alginate (25 mg/ml) and HA (0.25 
mg/ml) was extruded into a crosslinking solution of 100 mM CaCl2, 0.1 % polyethyleneimine, 
and 0.95 % polyvinyl alcohol. The extrusion of alginate-HA was performed layer-by-layer to 
achieve a cuboid scaffold with dimensions of 10 x 3 x 2 mm (Fig. 5.1a). The diameter of each 
strand was 80-100 µm and the interspace distance between the strands was 0.75 mm. In some 
scaffolds, fibronectin (0.1 mg/ml) and/or a suspension of PKH26-labelled primary rat Schwann 
cells (1.8 x 106 cells/ml) was homogenously mixed with the alginate-HA hydrogel solution 
before the scaffolds were fabricated.   
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Table 5.2. Groups of rats and procedure performed. 
 
Group No. of animals Procedure 
1. 5 Sham 
2. 4 Primary epineural repair 
3. 5 Alginate-HA scaffold 
4. 5 Alginate-HA scaffold with fibronectin 
5. 5 Alginate-HA scaffold with  Schwann cells 
6. 5 Alginate-HA scaffold with fibronectin and Schwann cells 
 
 
5.2.3 Experimental design and in vivo implantation of scaffold conduit 
Male Sprague-Dawley (SD) rats, weighing 250-300 grams each were randomly divided 
into 6 groups (n = 4 - 5), as shown in table 1. The in vivo studies were performed after approval 
by the University Committee on Animal Care and Supply (of the University of Saskatchewan). 
The animals were anesthetized with isoflurane (1.5 – 2% with oxygen; flow rate of 0.8 to 1 
L/min) and under aseptic conditions the left sciatic nerve was exposed after a skin incision along 
the femoral axis and blunt dissection of the underlying muscles. The nerve was either transected 
(for group 2) or resected (10 mm), 1 cm above its trifurcation. In the transected nerve, the ends 
were approximated and secured using two 8-0 sutures. In the groups of rats with scaffold implant 
(groups 3-6), a collagen sheet (Colactive Plus, Covalon) measuring 12 x 6 mm was placed 
beneath the nerve prior to its resection (Fig. 5.1b). After resection of the nerve, the scaffold was 
placed over the collagen sheet and approximated to contact both ends of the nerve. The collagen 
sheet was wrapped around the nerve and 15 µL of fibrin glue was instilled around the collagen 
and the nerve at both ends. In the sham-operated group, the sciatic nerve was only exposed 
without being damaged. In all animals, the muscles were reapposed with 6-0 polyglactin sutures 
and the skin was sutured using 4-0 silk. Post-operative buprenorphine injections (0.05 mg/kg) 
were provided for all animals every 8 hours, until the end of 24 hours. All the animals were 
housed separately in a temperature-controlled room with 12 hours light and 12 hours dark cycle. 
Food and water was available ad libitum. Grannick’s bitter apple deterrent solution (Greenwich, 
CT, USA) was sprayed daily on the feet of all animals to prevent them from chewing their toes. 
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Frequent monitoring of all animals for autotomy was performed. The animals were sacrificed at 
the end of 8 weeks or when they showed signs of severe autotomy. 
 
5.2.4 Behavioral study 
Sciatic Functional Index (SFI) is useful in the evaluation of functional motor recovery of 
the sciatic nerve (Monte-Raso et al., 2008). The foot pads of the rats were inked and they were 
allowed to walk over a sheet of paper placed in a box with dimensions of 50 x 8 cm. The clearly 
demarcated footprints were analyzed for various parameters. The SFI was estimated pre-
operatively in all animals and once every week (post-operatively). The Bain formula was used to 
calculate SFI and is given by: 
 
   SFI = -38.3*[(EPL-NPL)/NPL]+109.5*[(ETS-NTS)/NTS]+13.3*[(EIT-NIT)/NIT]- 8.8..(5.1) 
 
where EPL is the print length in the operated leg, ETS is the total toe spread in the operated leg 
and EIT is the intermittent toe spread in the operated rat. NPL, NTS and NIT are similar 
parameters on the normal leg. Print length is the longitudinal distance between the tip of the 
longest toe and the heel, total toe spreading is the cross-sectional distance between the first and 
fifth toes and intermediate toes spread is that between the second and the fourth toes (Fig. 5.2). 
 
5.2.5 Immunohistochemistry  
The animals were sacrificed at the end of eight weeks from the day of scaffold 
implantation or nerve transection. They were anesthetized by administering pentobarbital (80 
mg/kg) intraperitoneally. Transcardial perfusion and fixation of the rats was performed using 
cold phosphate buffered saline and 4% paraformaldehyde respectively. The left legs of the 
animals were dissected to extract the sciatic nerve. The nerve specimen were stored in 4% 
paraformaldehyde for 12 hours and transferred to sucrose (0.2 g/ml) for 1 day. They were then 
transferred to cryomolds (Tissue-Tek) filled with optimum cutting temperature embedding 
solution (OCT) and frozen. Longitudinal sections (10-12 μm thick) of the nerve specimen were 
obtained using a cryostat and mounted on gelatin subbed glass slides. Immunohistochemistry for 
S-100 and βIII-tubulin was done using antibodies (1:1000 dilution; Sigma-Aldrich, ON, Canada) 
against each of the proteins. The immunoreaction was visualized by using a secondary 
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fluorescent antibody (1:500 dilution; Life technologies, ON, Canada). Small square-shaped 
images (n=25) of the dimension 150 µm x 150 µm were acquired randomly at regions, both 
proximal and distal to the initial nerve injury using a fluorescent microscope (Carl Zeiss Axio 
Imager A1). The immunoreactivity was assessed by measuring mean gray value from these 
images using the software ImageJ (National Institutes of Health, Bethesda, Maryland, USA) and 
is presented as a ratio between the distal and proximal site (Berg et al., 2013).   
 
 
Figure 5.2 Measurements used in the calculation of sciatic function index (SFI).20 
 
5.2.6 Statistical analysis 
All data is expressed as the mean ± standard error of the mean (SEM). One-way analysis 
of variance (ANOVA) was used for comparison between groups. p<0.05 was considered as 
statistically significant. Data analysis was performed using Prism (GraphPad Software, San 
Diego, CA, USA). 
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5.3 Results and discussion 
5.3.1 Purity of Schwann cell culture and PKH26 staining 
 The primary Schwann cells were maintained in culture and repeatedly passed until there 
were no fibroblasts in the culture. The purity of the culture was ascertained at the end of 5 
passages by performing immunochemistry for S-100 (Fig. 5.3). All the cells stained for S-100, 
indicating that the culture contained only Schwann cells.  
 
 
Figure 5.3 S-100 immunohistochemistry (green) on primary Schwann cells with DAPI staining 
(blue) of nuclei (scale bar = 100 µm).21 
 
 PKH26-labelled primary Schwann cells (Fig. 5.4a) were maintained in vitro culture and it 
was found that the fluorescence intensity of the dye was stable even at the end of two months. 
PKH26 is a lipophilic dye that labels the cell membrane and has low cytotoxicity than other 
cytoplasmic or nuclear dyes (Horan and Slezak, 1989). The mean gray value of the cells on day 3 
was 82±4.6 (Fig. 5.4b). This decreased to 47±5.2 by the end of two months. However the 
labelled cells could still by visualized by increasing the exposure time on the imaging camera. 
PHK26 has been used for in vivo labelling of Schwann cells (Hermanns et al., 1997) and is 
suitable for long in vivo follow-up of labelled cells (Teare et al., 1991). In our study the 
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fluorescence of PKH26-labelled Schwann cells was still appreciated at the end of 2 months. With 
promising in vitro labelling, the membrane marker was also used for the in vivo studies.  
 
 
Figure 5.4 a) Primary rat Schwann cells labelled with PKH26 at 2 weeks in culture (scale bar = 
100 µm) b) Mean gray values of PKH26-labelled Schwann cells assessed in vitro at indicated 
times in culture. Significant difference between mean gray value at day 03 and that on other days 
in culture is (p<0.0001)] is indicated by *. No significant difference (ns) on comparison between 
days 7, 14, 30, and 60 (n= 25).22 
 
5.3.2 Implantation of the scaffold conduit 
 The alginate-HA scaffold implanted in the animals resulted in anatomical continuity of 
the nerve at the end of 8 weeks (Fig. 5.5). Alginate has been suggested to be a suitable nerve 
conduit material as residual material is not found within the regenerated nerve (Sufan et al., 
2001).  At the concentration of alginate used in this study, more than 50% of HA can be retained 
within the scaffold for a prolonged period (Lindenhayn et al., 1999). 
 PKH26-labelled Schwann cells were visualized in nerve sections obtained from an 
animal, which was sacrificed at the end of one week (due to autotomy). On Fig. 5.6, the nerve 
section is stained for S-100 protein (green color), and cell nuclei (blue color) using 4',6-
diamidino-2-phenylindole (DAPI). The orange colored cells represent the PKH26-labelled 
Schwann cells that were initially contained in the alginate-HA scaffold. However labelled 
Schwann cells were not seen in other animals at the end of 8 weeks. Immunohistochemistry for 
S100 was positive in all animals; indicating that other native Schwann cells did migrate into the 
nerve injury site.   
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Figure 5.5 Anatomical appearance of sciatic nerve repaired with alginate-HA scaffold at the end 
of 8 weeks.23  
 
Although PKH26 labels the cell membrane, diffusion of the dye can cause cytoplasmic 
labelling. Therefore this leads to low intensity of the dye in the replicated cells (Parish, 1999).  
Mosahebi et al. (2000), used Schwann cells labelled with PKH26 and found the dye to be stable 
in vivo for 4 weeks. Other gene transfer-free cell labelling dyes include a more stable 
cytoplasmic dye, carboxyfluorescein diacetate (Wang et al., 2005). Carboxyfluorescein has been 
used in vivo, to track oligodendrocyte precursor cells for more than a month (Kang et al., 2006). 
Similarly, Schwann cells have also been tracked in vivo (Li et al., 2003). Although gene transfer-
free labelling are promising, long-term studies would be more practical by inducing the 
expression of green fluorescent protein (GFP) in the cells. Schwann cells isolated from 
transgenic SD rats expressing GFP have been stable for as long as 2 months in vivo (Woodhoo et 
al., 2007).   
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Figure 5.6 PKH26-labelled Schwann cells in section of alginate-HA scaffold recovered after 1 
week. Immunohistochemistry for S-100 (green) is also done and nuclei are stained with DAPI 
(blue). The PKH26 labelled Schwann cells (red) appear orange, as they are merged with the 
staining for S-100 (scale bar = 100 µm).24  
 
5.3.3 Sciatic function index 
In general, a SFI value of approximately -10 to 0 indicates normal nerve function and that 
of approximately -100 or less indicates total dysfunction. As muscle contraction or muscle action 
potential measurements do not measure actual functional recovery, assessing SFI is crucial to 
assess functional efficacy of the nerve repair strategy (de Ruiter et al., 2014). After resection or 
transection of the sciatic nerve, the footprints showed an increase in print length (PL) and a 
decrease in the TS and ITS (Fig. 5.7). Unfortunately, assessing SFI in our study was not 
effective, as a result of low sample size because most animals showed autotomy of their toes. 
Besides one animal each from the alginate-HA and alginate-HA with fibronectin group, and all 
the sham animals, all other animals succumbed to the loss of one or more toes before the end of 
the study. The loss of digits in most animals, occurred within the end of 4 weeks, similar to 
another study that used SD rats (Weber et al., 1993). SFI therefore does have its limitations due 
to the development of muscular contractures (Dellon and Mackinnon, 1989) and/or autotomy in 
rats that have complete transection or resection of the sciatic nerve. Although certain strains of 
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rats have lower incidence of autotomy, preventing contractures of the hind paws after sciatic 
nerve injury is challenging. Therefore studies have suggested the measurement of the ankle 
angle, instead of footprint analysis (Varejão et al., 2003). Due to the increased incidence of 
autotomy in our study, we maintained a timeline of autotomy. 
 
Figure 5.7 Foot prints of a) rat from sham group and b) rat with left sciatic nerve resection and 
repair using alginate-HA scaffold at week 2 after surgery.25 
 
5.3.4 Autotomy timeline 
 In contrast to other studies that record autotomy scores (Inbal et al., 1980; Wall et al., 
1979), we maintained a timeline of when injury (bite wounds with inflammation) and loss of 
digits occurred in each animal (Fig. 5.8). By the end of 8 weeks, it was noted that only 1 animal 
in each group (except those with scaffolds including Schwann cells) with damage to the nerve 
had not lost any digit. The sham animals showed no signs of autotomy at any point in the study. 
As in previous studies, autotomy in our animals, began with biting of the toes and proceeded to 
loss of the entire toe(s). However in one animal, autotomy was atypical, beginning at the heel 
and proceeding to the leg. Due to extensive damage, this animal was sacrificed at the end of one 
week after the surgery.  
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Figure 5.8 a) Occurrence of damage to toe(s) b) Occurrence of complete loss of toe(s). Each dot 
represents the occurrence of the event in an animal.26  
 
Autotomy is frequently seen in animals with limb denervation and is considered to be an 
equivalent of neuropathic pain (Mogil, 2009). Various approaches have been used to prevent 
this. We tried using a bitter deterrent solution to prevent autotomy as described in few other 
studies (Hadlock et al. 2004; Milligan et al., 1999; Hadlock et al. 2005). However the failure of 
this intervention is clearly evident from the extent of autotomy in our study. Other approaches on 
preventing autotomy include the use of tricyclic antidepressants (Seltzer et al. 1989), 
corticosteroids (Kingery et al. 1999), magnesium sulphate (Feria et al., 1993), and tryptophan 
(Abbott and Young, 1991). The occurrence of autotomy is also regulated by the technique of 
neurectomy (Zeltser et al., 2000), genetic factors (Inbal et al., 1980), and the strain of rats used 
(Carr et al., 1992). Lewis rats have a decreased tendency towards autotomy behavior following 
the implantation of nerve conduits in resected sciatic nerve repair (Harley et al., 2004; Berrocal 
et al., 2013). In a preliminary study, we performed the similar surgical procedure on Lewis rats 
and found no autotomy on short-term survival (2 weeks). The use of Lewis rats would therefore 
be more practical for long-term functional studies.  
  
5.3.5 Immunohistochemistry 
The expression of genes and protein synthesis vary at the proximal and distal ends of the 
injured nerve (Jiang et al., 2014; Li et al., 2014). βIII-tubulin, a neuron-specific microtubular 
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protein (Karki et al., 2013), is localized in the axons of peripheral nerves. After axotomy, the 
expression of βIII-tubulin is upregulated at the proximal end of the nerve and it eventually 
increases at the distal end of the nerve (Hoffman et al., 1992). As regeneration occurs, there is 
increased βIII-tubulin immunoreactivity at the distal end. The intensity of immunoreactivity to 
specific proteins, expressed as mean gray value levels has been used to quantify protein 
expression in peripheral nerve sections (Orita et al., 2013; Nadeau et al., 2014). 
Immunoreactivity to specific proteins at the distal nerve end is compared to that expressed in the 
proximal end (Berg et al., 2013) and their ratio is used to quantify regeneration. In this study, 
βIII-tubulin was quantified in both the proximal and distal ends of the nerve (Fig. 5.9). The ratio 
of the distal to proximal mean gray values of βIII-tubulin, was 0.94 ± 0.02 in the sham group and 
0.95 ± 0.02 in the group with primary epineural suture repair. Similar immunoreactivity on either 
nerve ends in the primary epineural suture repair group suggest the occurrence of axonal 
regeneration from the proximal to the distal end. However in all the other groups with nerve 
resection and alginate-HA scaffold implant, the ratio was lower (0.63 ± 0.02 for the alginate-HA 
group). This reduction in the ratio was statistically significant when compared with either the 
sham or the primary epineural suture repair group. The addition of fibronectin or Schwann cells 
resulted in higher mean values of immunoreactivity (0.66 ± 0.02 and 0.64 ± 0.01 respectively). 
However there was no significant difference in the βIII-tubulin immunoreactivity when 
compared with the alginate-HA group. In the group with fibronectin and primary Schwann cells 
incorporated to the alginate-HA scaffolds, the ratio was lower (0.41 ± 0.02). Therefore there was 
no synergistic effect on incorporating fibronectin and Schwann cells.  
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Figure 5.9 Ratio between the mean gray values of β-III tubulin immunoreactivity in the distal 
nerve end to that of the proximal end in each treatment group. Significant difference between 
epineural suture repair group and other animal groups (p<0.0001)] is indicated by * (n= 25 from 
each animal in all groups).27 
 
 Although the dissected sciatic nerves from the animals, showed anatomical continuity 
without neuroma formation at the end of 8 weeks, βIII-tubulin immunoreactivity in the distal 
nerve end was low (Fig. 5.10). Therefore the scaffolds used in the study do not seem to be 
favorable towards axonal guidance. Covalently crosslinked alginate scaffolds have been used 
successfully in nerve regeneration (Sufan et al., 2001; Wu et al., 2002). The use of ionic 
crosslinking in this study may have resulted in early degradation of alginate. Although ionically 
crosslinked alginate have been used earlier, poly(L-lactide-co-D,L-lactide) or polyurethane tubes 
were used as conduits (Szarek, 2012). Collagen is a preferred nerve conduit due to its 
permeability. The collagen type-I sheet used in this study lacked adequate mechanical strength 
when compared with other synthetic polymers. Crosslinking of the collagen in this study would 
have retained permeability as well as mechanical strength.  
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Figure 5.10 βIII-tubulin immunoreactivity in longitudinal sections of sciatic nerve from a rat 
treated with primary epineural suture; a) at the proximal end of the transected nerve b) at the 
distal end of nerve. βIII-tubulin immunoreactivity in rat treated with alginate-HA scaffold 
implant; c) at the proximal end of initially resected nerve d) at the distal end of nerve (scale bar = 
100 µm).28 
 
The Schwann cells within the alginate-HA scaffolds had spherical morphology, rather 
than their usual bipolar morphology. Axonal guidance is more effective when Schwann cells 
retain their bipolar morphology. Also Schwann cell infiltration into the scaffold is higher in 
porous alginate scaffolds when compared with hydrogels (Loebsack et al., 2001). Fibronectin 
improves the outcome of Schwann cell proliferation in alginate (Mosahebi, Wiberg, and 
Terenghi, 2003); however in the absence of covalent binding with the alginate-HA, diffusion of 
fibronectin from the scaffold is a concern. These drawbacks of using a polysaccharide-based 
scaffold material, such as alginate can be eliminated by the use of collagen or fibrin-based 
scaffolds.  
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5.4 Conclusions 
 Recent progress in 3D printing has enabled the fabrication of intricate and porous 
hydrogel scaffolds containing living cells. In this study we used 3D printed alginate-hyaluronic 
acid scaffolds with or without Schwann cells and/or fibronectin, enclosed within a collagen sheet 
as nerve repair conduits. At the end of 2 months, despite the anatomical continuity of the 
resected nerve, it was found that only few axons regenerated across the injury through the 
scaffolds. The addition of Schwann cells and/or fibronectin did not influence the regeneration of 
axons across the resected nerve. As polysaccharide hydrogels are less very favorable for 
Schwann cells, protein-based hydrogels like collagen and fibrin would be better suited materials 
for fabricating nerve repair scaffolds. Autotomy has always been a concern in rats with complete 
nerve transection or resection. As SD rats have a high incidence of autotomy, Lewis rats are 
more practical for long-term nerve regeneration studies, involving functional assessment.   
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CHAPTER 6 
AN IN VITRO COMPARISON OF THE 3D BIOPRINTING OF ALGINATE, COLLAGEN, 
AND FIBRIN HYDROGELS FOR USE IN NERVE TISSUE ENGINEERING* 
 
*This chapter has been submitted as “Rajaram A, England S, Schreyer D, Chen XB. An in vitro 
comparison of the 3D bioprinting of alginate, collagen, and fibrin hydrogels for use in nerve 
tissue engineering” to the Journal of Tissue Engineering and Regenerative Medicine on February 
19, 2015. 
 
6.1 Introduction 
 Schwann cells are the resident glial cells of the peripheral nervous system that normally 
myelinate or ensheath axons to improve conduction velocity and provide metabolic support 
(Salzer, 2012). When a peripheral nerve is injured, Schwann cells help scavenge myelin debris 
and proliferate to form highly aligned arrays in the distal nerve segment called the bands of 
Büngner (Chaudhry et al., 1992) within spaces confined by retained basal lamina tubes (Bunge, 
1994). Guidance of regenerating axons is greatly influenced by extracellular matrix proteins in 
the basal lamina of Schwann cells (Nguyen et al., 2002). Schwann cells also produce 
neurotrophic factors that promote axon regeneration. During peripheral nerve regeneration, 
Schwann cells migrate ahead of the extending axonal growth cones to guide axons (Torigoe et 
al., 1996). Regenerating axons that grow in proximity to the bands of Büngner and the basal 
lamina have greater success at reaching their end organ (Campbell, 2008). On the contrary, 
axons that ‘miss’ the bands of Büngner often end up being misaligned and may form a neuroma 
(Ide, 1996). In the event of a breech in the continuity of the existing basal lamina at the distal end 
of the injured nerve, Schwann cells must accompany the regenerating axons to facilitate repair 
(Sketelj et al., 1989). Schwann cell morphology and migration are crucial for axonal 
regeneration and remyelination (Lobsiger et al., 2002). In tissue culture, Schwann cells may have 
unipolar, bipolar, or multipolar morphology, with the bipolar morphology being most common 
(Wang, et al., 2012). These polarized morphologies are correlated with substrate adhesion and 
high motility and Schwann cells can transform from one morphology to another depending on 
the substrates or materials in their vicinity (Vu et al., 2014).  
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Various biomaterials, like alginate, collagen, gelatin, fibrin, chitosan, and other synthetic 
polymers, have been used as luminal fillers in tissue repair scaffolds for nerve tissue engineering 
applications (Jiang et al., 2010). The interaction of Schwann cells with these materials affects 
cell proliferation, migration, and differentiation. Collagen and fibrin, in particular, are commonly 
used luminal fillers, as they are naturally occurring components of the extracellular matrix.  
Although alginate is not a component of the nerve matrix, its biocompatibility makes the 
incorporation of Schwann cells feasible. It can be rapidly crosslinked by calcium ions and its 
physical properties can be tuned. Freeze-dried alginate permits axonal regeneration across long 
gaps and has been used to repair 5 cm defects in cat sciatic nerves (Suzuki et al., 1999). 
Crosslinked alginate sponges without tubular conduits or nerve guidance channels have also been 
used to repair peripheral nerve injuries (Sufan et al., 2001). It has also been shown that chick 
embryo dorsal root ganglia (DRG) extend longer axons when they are co-cultured with Schwann 
cells in alginate (Mosahebi et al., 2001). Alginate with incorporated cells can be 3D-printed as 
scaffolds for tissue repair (Rajaram et al., 2014). 
Collagen promotes neurite outgrowth in vitro and when used in vivo as a luminal filler in 
nerve conduit channels, it leads to improved sensory function (Jin et al., 2013). Axon extension 
in collagen is augmented in the presence of Schwann cells. Rolled sheets of collagen gel with 
incorporated Schwann cells have been proposed as potential nerve repair conduits (Goto et al., 
2010). Three-dimensional (3D) collagen scaffolds have been printed using a cryogenic direct-
plotting system, where the extruded collagen is immediately frozen to retain its structure (Kim et 
al., 2009).  
Fibrinogen from blood plasma is converted by thrombin to fibrin and is incorporated as a 
temporary extracellular matrix protein of the nerve (Akassoglou et al., 2000). Fibrin gel has been 
used as a vehicle to deliver nerve growth factor (Sakiyama-Elbert and Hubbell, 2000) and fibrin 
containing Schwann cells has been used as a luminal filler to promote axonal regeneration (Galla 
et al., 2004). The addition of neurotrophins along with Schwann cells into fibrin has also been 
used for the regeneration of rat sciatic nerves (Ma et al., 2013). Inkjet 3D printing has enabled 
layers of neural cells and fibrin to be stacked over each other to form a 3D nerve repair scaffold 
(Xu et al., 2006).  
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Recently, 3D biofabrication techniques have been drawing much attention for the 
fabrication of hydrogel-based nerve repair scaffolds. One key strategy in these scaffolds is the 
formation of structures resembling the bands of Büngner (Ribeiro-Resende et al., 2009). 
Micropatterning cells with high resolution cannot be achieved using current bioprinting 
techniques (Derby, 2012). While this is feasible with laser-based microfabrication techniques, 
photon-induced cellular damage and transfer of metallic particles along with the deposited 
hydrogel or cells are a few drawbacks (Smausz et al., 2006). Therefore, 3D bioprinting of 
appropriate hydrogels that enable Schwann cell alignment is a practical strategy. Because 
Schwann cell morphology influences the outcome of nerve repair, inducing favorable cell 
morphology in 3D culture is crucial. Alignment is another important parameter to be considered. 
Cell alignment can be induced by forming grooves on culture surfaces (Kim et al., 2007), 
fabricating microchannels (Sarig-Nadir et al., 2009), micropatterning (Nikkhah et al., 2012), or 
by using extracellular matrix proteins as haptotatic cues (Zhu et al., 2010). Schwann cells 
aligned using micropatterning techniques can direct neurite outgrowth (Thompson and Buettner, 
2004; Schmalenberg and Uhrich, 2005). 
In this study, we examined the suitability of various hydrogels that are potentially useful 
in nerve tissue engineering, including alginate, collagen type-I, fibrin, and composite hydrogels 
composed of alginate with collagen type-I or fibrin with hyaluronic acid. The fidelity of printing 
each of these hydrogels using a commercial 3D printer is examined. The viability, morphology, 
and alignment of Schwann cells within these hydrogels are also studied. Our findings provide 
guidance for future strategies to engineer the creation of 3D bands of Büngner for in vivo nerve 
repair.  
 
6.2 Methods 
6.2.1 Preparation of the hydrogels 
Alginate 
Alginate (from brown seaweed) (Sigma, Oakville, ON, Canada) was dissolved in 0.3 M sucrose 
and 4.2 mM HEPES buffer (pH 7.4) and was used at a concentration of 20 mg/ml. The 
osmolality of the alginate solution was made physiological by using sucrose. Solutions 
containing phosphate ions were avoided as they affect the crosslinking of alginate (Drury et al., 
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2004b). The alginate was crosslinked for 5 minutes in a solution containing 20 mM calcium 
chloride, 110 mM sodium chloride, and 20 mM HEPES.    
Collagen type-I 
Collagen type-I solution from rat tail (4 mg/ml from Advanced Biomatrix, CA, USA) was mixed 
in equal volume with a neutralizing solution containing 10% Dulbecco’s modified Eagle’s 
medium (DMEM), 10% fetal bovine serum (FBS), 10% 0.1 N sodium hydroxide, and 20% of 
concentrated (3.5x) DMEM. Both the solutions were kept in ice, until being mixed together. The 
final concentration of collagen was 2 mg/ml.  
Fibrin 
Fibrinogen from bovine plasma (Sigma, Oakville, ON, Canada) was dissolved at 20 mg/ml with 
0.5 mg/ml of aprotinin, a serine protease inhibitor because Schwann cells secrete the fibrinolytic, 
plasminogen activator (Krystosek, 1984), which can result in degradation of fibrin. Human 
thrombin (from Tisseel kit, Baxter, Canada) at a final concentration of 4.2 U/ml in a solution 
containing 20 mM calcium chloride, 110 mM sodium chloride, and 20 mM HEPES, was used to 
gel the fibrinogen for 5 minutes to form fibrin.  
Alginate/collagen type-I 
Alginate (40 mg/ml) was mixed with neutralized collagen (2 mg/ml) at a ratio of 1:1. The 
resulting hydrogel, containing 20 mg/ml alginate and 1 mg/ml collagen type-I was left in room 
temperature for 2 minutes and then crosslinked for 5 minutes with a solution containing 20 mM 
calcium chloride, 110 mM sodium chloride, and 20 mM HEPES. 
Alginate/fibrin 
Alginate (40 mg/ml) was mixed with a solution of fibrinogen (40 mg/ml) and aprotinin (1 
mg/ml), at a ratio of 1:1. Thrombin (final concentration of 4.2 U/ml) was instilled into the 
hydrogel to initiate gelling of the fibrinogen. After 2 minutes, the crosslinking was completed by 
using a solution containing 20 mM calcium chloride, 110 mM sodium chloride, and 20 mM 
HEPES. 
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Fibrin/hyaluronic acid 
Fibrinogen (20 mg/ml) containing 0.5 mg/ml of aprotinin was mixed with 4 mg/ml of hyaluronic 
acid sodium salt (Sigma, Oakville, ON, Canada) at a ratio of 1:5. Human thrombin (final 
concentration of 4.2 U/ml) in a solution of 20 mM calcium chloride, 110 mM sodium chloride, 
and 20 mM HEPES, was used to gel the fibrinogen/hyaluronic acid mixture for 5 minutes.  
 
Table 6.3. Extrusion pressure and printing speed used for bioprinting hydrogels. 
Hydrogel Extrusion pressure 
(Barr) 
Printing speed (mm/s) 
Alginate 0.3 12 
Collagen type-I 0.1 12 
Fibrin 0.1 16 
Alginate + collagen type-I 0.3 12 
Alginate + fibrin 0.3 12 
Fibrin + hyaluronic acid 0.1 12 
 
6.2.2 Printing of hydrogel strands  
A 3D-Bioplotter (envisionTEC, Gladbeck, Germany) was used to print single-layered 
patterns using each of the hydrogels. The hydrogel solutions were extruded into respective 
crosslinking or gelling solutions (except collagen type-I) through steel-tip dispensing needles 
(EFD Nordson, Westlake, OH, USA) with an internal diameter of 100 µm. When using 
extrusion-based biofabrication, parameters such as the speed of dispensing head, extrusion 
pressure, and flow rate of the material must be optimized in order to obtain continuous scaffold 
strands (Li, et al., 2009). The speed of printing was 12 mm/s for all of the gels (except for fibrin, 
which was 16 mm/s). The extrusion pressure was adjusted depending on the viscosity. Hydrogels 
of low viscosity were printed with 0.1 bar, while alginate and alginate-based gels were printed 
with 0.3 bar. Fibrin is less viscous and therefore a lower printing speed and pressure was used. 
The extrusion pressure and speed of printing for each hydrogel is given in Table 6.1. 
     87 
Alginate and alginate/collagen type-I were printed into a solution containing 20 mM 
calcium chloride, 110 mM sodium chloride, and 20 mM HEPES. Fibrin and alginate/fibrin were 
printed into the same solution with added thrombin (25 U/mL). Collagen type-I was printed onto 
a dry slide and then incubated at 37°C to gel for 5 minutes. A schematic of the printing method 
used is shown in Fig. 6.1. 
 
Figure 6.1 a) Bioprinting into a crosslinking/gelling solution for alginate, alginate/fibrin, 
alginate/collagen, fibrin, and fibrin/hyaluronic acid. b) Bioprinting in air for collagen type-I. c) 
Schematic of a printed single layered strand.29 
 
6.2.3 Print fidelity 
 Strand print fidelity depends on the physical properties of the extruded hydrogel and the 
accuracy of the machine (Chung et al., 2013). To assess the final morphology of printed strands, 
we measured the areas occupied by the materials after extrusion to the intended area, as reported 
previously (Rajaram et al., 2014). Briefly, the 3D-Bioplotter® was used to extrude each of the 
hydrogel in a pattern as shown in Fig. 6.1c. The intended strand dimension was 100 µm (similar 
to the internal diameter of the dispensing needle) and the interstrand spacing was programmed to 
be 650 µm on the software controlling the machine. Final adherence to these parameters was 
     88 
assessed from measurement of images of the printed strands and compared with the intended 
dimensions.  
 
6.2.4 Isolation of rat primary Schwann cells 
Enriched primary rat Schwann cells were isolated from the sciatic nerves of Sprague-
Dawley rats using a D-valine selection method (Kaewkhaw et al. 2012). Briefly, the sciatic nerve 
was isolated, the epineurium was removed and the nerve was cut into 2 mm fragments. The 
fragments were digested with collagenase for 1 hour. The resulting cell suspension was filtered 
and cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) containing D-valine (instead of 
L-valine), 10% fetal bovine serum (FBS) and mitogens (forskolin, N2 supplement, and bovine 
pituitary extract). The presence of only D-valine successfully suppresses fibroblast overgrowth. 
 
6.2.5 Schwann cell viability and proliferation  
Primary Schwann cells were added to the hydrogels at a density of 5 x 105 cells/ml. The 
cells were suspended in 10 µl of DMEM, added directly to the alginate, fibrinogen, or 
neutralized collagen type-I and mixed by repeated pipetting. For the alginate-based composite 
hydrogels, the cell suspension was added into the alginate solution, prior to mixing with either 
fibrinogen or collagen type-I. 5 µL droplets of each hydrogel containing primary Schwann cells 
was pipetted into the wells of a 96-well tissue culture plate. To prevent the hydrogels droplets 
from dislodging, the plate was coated previously with a solution of 0.5% polyethyleneimine and 
thoroughly washed with sterile distilled water. Each hydrogel was gelled or crosslinked as 
mentioned before and maintained in DMEM with 10% fetal bovine serum in a 37°C humidified 
incubator containing 5% CO2. 
Viability of Schwann cells was assessed on day 3 in culture. The culture medium was 
replaced with DMEM containing calcein-AM (1 µg/ml, AnaSpec, CA, USA) and propidium 
iodide (10 µg/ml, AnaSpec, CA, USA) and the hydrogel samples were incubated for 1 hour at 
37°C. Images of the stained cells in the hydrogels were captured using a fluorescence 
microscope (Axiovert 100, Zeiss). The images (n=5) were analyzed using ImageJ (National 
Institutes of Health, MD, USA). Cell viability was ascertained from the ratio of live cells (green 
fluorescent) to total cells (green + red fluorescent) in the images captured.  
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 Because Schwann cell viability was found to vary little between culture conditions, total 
cell number was used to estimate cell proliferation over time. Proliferation of Schwann cells 
within hydrogels (Galateanu et al., 2012) was assessed on days 3 and 7, using 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. MTT solution (5 mg/ml) 
was added to the culture medium of each well and the gels were incubated for 5 hours at 37°C. 
The medium was aspirated and 1 ml of dimethyl sulfoxide (DMSO) was added to each well. The 
hydrogel droplets were mechanically disrupted to thoroughly solubilize the formazan contained 
within them. The resulting solution was centrifuged to remove hydrogel fragments and 200 µl of 
the supernatant was plated into another 96-well plate. The absorbance of the supernatant (n=5) 
was measured at 560 nm using a micro-plate reader (Molecular Devices SpectraMax 340, 
California, USA). The blank absorbance value of each hydrogel (from hydrogels containing cells 
but not treated with MTT) was subtracted.  
 
6.2.6 Schwann cell morphology 
 To assess morphology of Schwann cells cultured in the hydrogels, similar droplet 
cultures as done for viability assessment were prepared. Schwann cells were stained using 
calcein-AM (1 µg/ml) on days 1, 3, and 10, and fluorescent images were captured. Morphology 
was analyzed by calculating circularity using the software ImageJ. Circularity is a measure of the 
roundedness of a cell, related to its area and perimeter, and can theoretically range between 0 and 
1, with 1 indicating a perfect circle (Wittmer et al., 2007).  
 
6.2.7 Schwann cell alignment in printed strands 
To assess alignment of cells in printed strands, primary Schwann cells were mixed into 
each hydrogel at a density of 4 x 105 cells/ml and single strands of 10 mm length were printed 
into the respective gelling or crosslinking solutions (except collagen type-I) using the same 
printing parameters as mentioned earlier. Each hydrogel was crosslinked or gelled for 5 minutes, 
after which it was maintained in culture in DMEM with 10% FBS in an incubator at 37°C. The 
cells in the hydrogel strands were stained with calcein-AM on day 3, as described above, and 
fluorescent images were collected for analysis.  
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6.2.8 Statistical analysis 
All data is expressed as the mean ± standard error of the mean (SEM). One-way analysis 
of variance (ANOVA) with Bonferroni post-test correction was used for comparison between 
groups. p<0.05 was considered as statistically significant. Data analysis was performed using 
Graphpad Prism (GraphPad Software, San Diego, CA, USA). 
 
6.3 Results 
Single-layered hydrogel strands were printed by extruding material through a dispensing 
needle with an internal diameter of 100 µm. Alginate crosslinks instantly on interaction with 
calcium ions, and fibrinogen gels quickly in the presence of thrombin and calcium ions. Printed 
strands of alginate and alginate/fibrin were linear and uniform in dimension (Fig. 6.2a, 6.2c, 
6.2f). However, the final strand width of fibrin gels is greater than alginate as the gelation of 
fibrinogen is not as quick as the crosslinking of alginate (Fig. 6.2e). The addition of hyaluronic 
acid made the fibrinogen solution more viscous and the strand width was significantly decreased 
(Fig. 6.2f).  Unlike fibrin and alginate, collagen type-I did not gel quickly. On printing, collagen 
type-I spread out on the printing surface. By the time complete gelation after incubation at 37°C 
occurred, individual strands had coalesced such that interstrand spaces were eliminated (Fig. 
6.2d). Even when mixed with alginate, the collagen type-I spread out and the strand width was 
significantly higher than alginate alone and alginate/fibrin (Fig. 6.2b, 6.2c).  
The strand width and interstrand spacing of each hydrogel is shown in Fig. 6.3. It is seen 
that alginate represents the intended dimensions more closely than the other hydrogels (strand 
width of 120 ± 5.3 µm and interstrand space of 629 ± 6.9 µm). Fibrinogen was printed into a 
solution containing thrombin; however, its dimensions were larger than those intended. The 
addition of hyaluronic acid decreased the strand width from 787 ± 23 µm to 183 ± 3.7 µm and 
the interstrand space was increased from 42 ± 11 µm to 555 ± 8.9 µm. Collagen type-I could not 
be printed into strands.  
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Figure 6.2  3D printed strands of a) alginate b) alginate/collagen type-I c) alginate/fibrin d) 
collagen type-I e) fibrin f) fibrin/hyaluronic acid.30 
 
 A live/dead assay, using calcein-AM and propidium iodide staining, was done to compare 
the biocompatibility of the different hydrogels. Primary Schwann cells were cultured in hydrogel 
droplets. Cell viability, measured by calculating the percent of all cells that were still alive on 
day 3 in culture, was very similar in all the hydrogels. Although viability trended highest in 
fibrin (89.2 ± 2.9), no significant statistical difference was found between different hydrogel 
formulations (Fig. 6.4a).  
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Figure  6.3 a) Strand width of printed hydrogels b) interstrand spacing between adjacent hydrogel 
strands [n = 5; *p<0.001 on comparing the strand width or interstrand space in each hydrogel 
with the respected intended dimension].31 
 
An MTT assay was used to assess proliferation of primary rat Schwann cells in each 
hydrogel (Fig. 6.4b). MTT assays have been used to study proliferation of cells cultured within 
hydrogels (Galateanu et al., 2012). On both day 3 and day 7, greater cell proliferation was 
observed in fibrin (absorbance of 0.248 ± 0.002 at day 3 and 0.696 ± 0.016 at day 7). Measured 
absorbance related to cell number in collagen type-I was low and that of alginate was the least 
(0.099 ± 0.004 at day 7). The addition of fibrin to alginate led to increased proliferation of 
Schwann cells. Besides fibrin, no other hydrogel showed a significant increase in the absorbance 
when maintained in culture over time. 
 
Figure 6.4  a) Schwann cell viability in different hydrogels at the end of day 3 b) MTT assay on 
day 3 and 7 [n=5; *p<0.0001 when compared with the control (tissue culture plate)]. 32 
 
Hydrogel droplets were also used to examine the morphology of incorporated cells. 
Schwann cells, normally multipolar in two dimensional culture, extended multiple processes 
when cultured within collagen type-I or fibrin. When cultured in alginate, they remained nearly 
spherical throughout the study. While the cells cultured in alginate/fibrin and alginate/collagen 
type-I attached and spread better than those in alginate, most cells remained spherical, unlike 
those in collagen or fibrin. On day 1, cell circularity was lowest in fibrin and collagen type-I 
(0.56 ± 0.02) (Fig. 6.5). On day 5, cells in alginate/fibrin had further slightly decreased their 
circularity. The results on day 10 were similar to those obtained on day 5.  
     93 
 
Figure 6.5 Circularity of primary Schwann cells cultured in various hydrogels [n = 5; *p<0.05 on 
comparing circularity of cells cultured in indicated hydrogels with those cultured in alginate].33 
 
Qualitative assessment of Schwann cells in printed hydrogel strands suggests that cell 
proliferation was highest in fibrin (Fig. 6.6j) confirming the results of proliferation assays (MTT) 
on droplet hydrogel cultures. Neutralized collagen-type I (Fig. 6.6i) could not be printed into 
strands and has many cells due to larger volume of the gel dispensed. Similarly as Schwann cell 
proliferation was found to be low in the presence of alginate, we observed fewer cells in printed 
strands containing alginate (Fig. 6.6f, 6.6g, and 6.6h). Schwann cells were also more spherical in 
printed alginate strands (Fig. 6.6f). Schwann cells were observed to be arranged along the edges 
of printed fibrin strands (Fig. 6.6e, 6.6j). Although Schwann cells incorporated into a fibrin 
droplet had a random pattern of process extension, those in the 3D printed strands are aligned 
along the longitudinal axis of the fibrin strand (Fig. 6.7). The addition of hyaluronic acid to 
fibrinogen also promoted the alignment of Schwann cells in printed strands (Fig. 6.8).  
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6.4. Discussion 
Extrusion-based bioprinting techniques depend on the physical properties and gelation of 
the hydrogel material (Chung et al., 2013). Alginate and alginate/fibrin did not spread out much 
because they were quickly crosslinked by calcium in the crosslinking solution. Fibrinogen was 
successfully printed into strands; however, the dimensions of fibrin strands were much larger due 
to its lower viscosity. Fibrinogen can be made more viscous by the addition of hyaluronic acid 
and can be gelled more quickly using a higher concentration of thrombin in the gelation solution. 
Collagen type-I could not be printed with the intended strand dimensions because of its low 
viscosity, as well as its slow and difficult to control gelation. 
Collagen scaffolds are generally fabricated by casting into a pre-formed mold and then 
crosslinked or frozen (Sachlos, 2003). Although these casting techniques result in good collagen 
scaffolds (Liu et al., 2008), the addition of cells into the collagen is not feasible because of the 
necessary crosslinking chemistry, or freezing step. Alginate/collagen type-I was successfully 
printed into strands, as the alginate was easily crosslinked. However, the presence of alginate 
affected Schwann cell morphology. To include incorporated cells in our study, collagen was 
neutralized prior to printing. Following neutralization, the viscosity of the gel changes with time 
and printing parameters such as speed and extrusion pressure must be adjusted accordingly. 
Printing collagen type-I led to either the extrusion of a large amount of material (due to lower 
viscosity) or clogging of the needle (as it had gelled in the needle before extrusion). Our findings 
suggest that achieving good print fidelity with collagen and progressing to complete scaffold 
fabrication would be very challenging. 
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Figure 6.6 Phase-contrast images of printed strands taken at day 3 in culture; a) alginate b) 
alginate/collagen type-I c) alginate/fibrin d) collagen type-I and e) fibrin. The corresponding 
fluorescent images showing Schwann cells stained with calcein-AM contained within the strands 
are also shown (f-j) [Scale bar = 100 µm].34  
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To improve the print fidelity of fibrinogen, we increased its viscosity by including 
hyaluronic acid, a natural glycosaminoglycan polymer (Fraser et al., 1997b). While a few studies 
state that fibrin could induce scarring of nerves, hyaluronic acid has been shown to prevent 
excessive surgical scarring during nerve repair (Ozgenel, 2003). When hyaluronic acid was 
added, printing of fibrinogen was easier and strand width and interstrand space were closer to the 
intended dimensions (Fig. 6.3a, 6.3b). Schwann cells continued to align along the edge of the 
strands in the presence of hyaluronic acid (Fig. 6.8). Thus, bioprinting fibrin enabled Schwann 
cell alignment and the incorporation of hyaluronic acid improved the fidelity of printing.  
 
 
Figure 6.7 a) Schwann cells (stained with calcein-AM) cultured in a droplet of fibrin b) 3D 
printed strands of fibrin containing Schwann cells [Scale bar = 100 µm].35 
 
The viability of Schwann cells cultured in hydrogels was high, as was expected because 
alginate, collagen type-I, and fibrin are natural biomaterials. Previous studies (Mosahebi et al., 
2001) involving long-term cultures of Schwann cells seeded over the same hydrogels resulted in 
good viability. Our study shows good viability of hydrogel incorporated Schwann cells for each 
of the compared formulations. Providing a suitable substrate to enable proliferation and long-
term survival of Schwann cells is vital. Although collagen-type I is a component of the nerve 
matrix, it has been observed that the proliferation of Schwann cells is low when they are seeded 
over collagen-type I coated surfaces (Vleggeert-Lankamp et al., 2004). Collagen type-I 
preparations from several different sources have been shown to impede the rate of DNA 
synthesis in glial cells (Eccleston et al., 1989). It is also know that this is not seen with collagen-
types III, IV, and V. In our study, though Schwann cell viability in collagen-type I was high, cell 
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proliferation was not inspiring. It has previously been shown that alginate can reduce viability 
and proliferation of Schwann cells in vivo (Pannunzio et al., 2005) likely because of its lack of 
cell binding domains (Dhoot et al., 2004). Cellular proliferation in alginate is also negatively 
influenced by its mechanical properties (Banerjee et al., 2009) and the mitotic activity of the 
cells is reversed when they are released from the hydrogel (Hunt et al., 2009). In this study, 
Schwann cell proliferation was lowest in alginate and the addition of collagen-type I or fibrin did 
not ‘rescue’ the cells.  
 
Figure 6.8 a) 3D printed fibrin strand containing Schwann cells (stained with calcein-AM) b) 3D 
printed fibrin/hyaluronic acid strand containing Schwann cells (stained with calcein-AM) [scale 
bar = 100 µm].36 
 
In order to recreate bands of Büngner in a nerve repair scaffold, we would hope to see 
elongation of Schwann cells indicative of cell adhesion and capacity for migration. Calcein-AM 
stains the cytoplasm of Schwann cells uniformly and has been used in the assessment of cell 
morphology (DeCoster et al., 2010). Alginate, though favorable for encapsulating pancreatic 
islet cells (Calafiore, 2003) and chondrocytes (Chia et al., 2004), is not ideal for the culture of 
Schwann cells due to their resulting spherical morphology. Better morphology is obtained by the 
addition of fibronectin (Mosahebi et al., 2003b) or other cell adhesion peptides (Liu et al., 2009). 
The morphology of Schwann cells in fibrin and collagen-type I remained bipolar with low 
circularity for up to 10 days in culture. Therefore, fibrin and collagen type-I would be more 
beneficial than unmodified alginate or alginate/fibrin and alginate/collagen type-I for the culture 
of Schwann cells. Kalbermatten et al. (2008), have shown that in the presence of fibrin, Schwann 
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cell adhered better to polyhydroxybutyrate nerve conduits. Schwann cell cultures in collagen 
type-I have good viability and morphology, but have a low proliferation rate. On the other hand, 
cultures in fibrin showed good viability, morphology, and proliferation.  
While Schwann cells in alginate-containing strands remained spherical, Schwann cells 
tended to align within printed fibrin strands. During printing the extruded material undergoes 
various shear stresses at the dispensing nozzle (Aguado et al., 2012). Fibrin filaments align 
themselves along the direction of induced stress (Hudson et al., 2010), so printing of fibrinogen 
by extruding it through a fine nozzle may induce fiber alignment. Because Schwann cells tend to 
align along fibrin filaments, the result is that the long axes of Schwann cells and the fibrin 
strands are parallel.  
Autologous platelet-rich fibrin matrices have been used successfully for nerve repair 
(Choi et al., 2005), but the mere filling of nerve conduit tubes with fibrin-rich plasma could 
prevent the longitudinal alignment of fibrin filaments (Williams, 1987). Pre-aligning the fibrin 
filaments and with them the incorporated Schwann cells is a good strategy. Magnetic fields 
(Dubey, 2001) or the continuous application of lateral strain (Matsumoto et al., 2007) can align 
fibrin fibrils. We show that 3D bioprinting of fibrinogen into a solution containing thrombin 
results in alignment of incorporated Schwann cells, probably due to the alignment of fibrin 
fibrils. As Schwann cells cultured in fibrin have good viability, the desired bipolar morphology, 
and also align when bioprinted, better strategies to improve bioprinting of fibrin need to be 
considered.  
 Fibrinogen forms an insoluble gel on interaction with thrombin, but the resulting fibrin 
fibrils become crosslinked only with the addition of activated factor XIII, also known as plasma 
transglutaminase (Kanaide and Shainoff, 1975). Incorporation of activated factor XIII during the 
3D printing of strands is expected to cause crosslinking of fibrin. Factor XIII also improves 
alignment of the fibrin filaments (Lorand, 2006) and the extensibility of individual filaments 
(Collet et al., 2005). It can also covalently bind extracellular proteins such as fibronectin to fibrin 
(Kanaide and Shainoff, 1975), possibly advantageous because Schwann cell proliferation is 
augmented by fibronectin (Baron-Van Evercooren et al., 1982). In our future studies, we intend 
to add factor XIII and fibronectin to fibrinogen/hyaluronic acid. Bioprinting into thrombin would 
activate factor XIII, and result in a more robust scaffold. As the cells align along the long axis of 
the printed strands, 3D bioprinting multiple layers of crosslinked fibrin strands could be used to 
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fabricate a nerve conduit mimicking the bands of Büngner. While synthetic polymers have been 
used to model the bands of Büngner in nerve conduits (Lietz et al., 2006), the use of natural 
biomaterials like fibrin may have additional advantages. A similar strategy could also be used to 
3D print autologous platelet rich fibrin matrix, to achieve better efficacy in nerve repair.      
 
6.5. Conclusions 
Advanced biofabrication techniques have enabled the inclusion of cells within tissue 
scaffolds. As morphological characteristics of Schwann cells determine the outcome of nerve 
repair, we compared the morphology and viability of Schwann cells cultured in naturally 
occurring hydrogels. Because they are proteins, fibrin and collagen type-I enabled better 
adhesion of Schwann cells and led to its more favorable bipolar morphology. With printing of 
collagen being complicated by its time-dependent gelation and varying viscosity, fibrin was 
found to be the more appropriate material for 3D printing. The bipolar Schwann cells aligned 
parallel to the long axis of the printed fibrin strands. The addition of hyaluronic acid to 
fibrinogen improved the accuracy of printing. This study suggests that strategic stacking of fibrin 
strands can be accomplished to create 3D scaffolds with a pattern of longitudinally arranged 
Schwann cells.  
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CHAPTER 7 
CONCLUSIONS AND FURTHER RESEARCH 
 
7.1 Conclusions  
Many techniques to improve nerve regeneration such as the incorporation of 
neurotrophins, and/or extracellular proteins have been explored earlier. Modification of nerve 
conduit materials has been achieved to make scaffolds more adhesive, thereby promoting nerve 
repair. Schwann cells are the principal cells of the peripheral nervous system and as such, 
incorporating them in nerve conduits is rational for nerve repair. This PhD research is aimed at 
fabricating scaffolds incorporating Schwann cells for nerve repair, with the conclusions surmised 
as follows.   
 
1) To enable the inclusion of Schwann cells in intricate nerve scaffold design, a unique 
technique of bioplotting was optimized, wherein the use of polyethyleneimine and 
polyvinyl alcohol in the crosslinking medium stabilized the structure of alginate-
hyaluronic acids scaffolds.   
2) The survival of Schwann cells during the bioplotting process was increased by plotting 
the hydrogel directly into the crosslinking solution, rather than plotting in air.  
3) Extruding hydrogels into crosslinking solutions with similar density and viscosity 
resulted in strands having their intended width and interstrand spacing, enabling a more 
porous scaffold structure.  
4) The addition of polyethyleneimine to alginate-based scaffolds result in more efficient 
entrapment and prolonged delivery of proteins. PEI also improves the mechanical 
properties and decreases the degradation of alginate-HA scaffolds. 
5) Alginate-based hydrogels are less favorable for Schwann cells culture and the guidance 
of axons than collagen and fibrin.  
6) Fibrin and collagen type-I enable better adhesion of Schwann cells in culture, leading to 
its more favorable bipolar morphology.  
7) Bipolar Schwann cells have a tendency to align parallel to the long axis of 3D printed 
fibrin strands.  
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8) Addition of hyaluronic acid, improves the 3D printing accuracy while printing most 
hydrogels, as it increases the viscosity of the composite hydrogel.  
9) Autotomy, a concern in rat sciatic nerve injury model, is also strain-dependent. Sprague-
Dawley rats have a high incidence of autotomy than Lewis rats. The use of Lewis rats 
would be more practical for long-term nerve regeneration studies, involving functional 
assessment.   
 
Extrusion-based bioprinting techniques depend on the physical properties and gelation of 
the hydrogel material. This research has shown that the properties of alginate can be modified by 
the addition of polyethyleneimine and hyaluronic acid. While alginate may not be appropriate for 
nerve regeneration, it is useful for the culture of chondrocytes and islet cells. The incorporation 
of PEI to alginate during these cultures will also be beneficial.  
Fibrin filaments align themselves along the direction of induced stress. While various 
techniques are used to align Schwann cells in hydrogels, this research has showed that the same 
can be achieved using 3D printing. During bioplotting the extruded hydrogel undergoes shear 
stresses at the dispensing nozzle. Therefore Schwann cells in fibrin, were shown to align along 
the long axis of the printed strands. 3D bioprinting multiple layers of crosslinked fibrin strands 
could be used to fabricate a nerve conduit with aligned Schwann cells.  
While other synthetic polymers have been used to model the bands of Büngner in nerve 
conduits, this research shows that natural biomaterials like fibrin may also be used. This similar 
strategy could also be extended to autologous platelet-rich fibrin matrices, which have been used 
successfully for nerve repair. As mere filling of nerve conduit tubes with fibrin-rich plasma 
prevents longitudinal alignment of fibrin filaments, 3D printing plate-rich fibrin using the 
techniques described in this research can be promising. 
 
7.2 Recommendations for future research 
Understanding cellular mechanisms of nerve repair can be used to further improve the 
engineering of biofabricated nerve scaffolds. Axonal misdirection is one of the primary reasons 
of nerve conduit failure. Dr. Sydney Sunderland, an anatomist, stated that “the core of the 
     102 
problem is not promoting axon regeneration, but in getting them back to where they belong” 
(Sunderland, 1978).  
Guiding axons to their end targets is the key to success for any nerve repair technique. 
During surgical anastomosis of transected nerves, fascicular groups on the proximal end of the 
nerve are anastomosed to their corresponding distal ends. Neglecting fascicular mapping while 
using nerve conduits could lead to axonal misdirection. Precise 3D printing techniques can be 
used to fabricate customized multichannel nerve conduits, which enable fascicular continuity. 
The bioplotting technique discussed in this dissertation can be helpful to achieve the fabrication 
of a complex nerve conduit.  
It has been shown that Schwann cells align along the strands when fibrin is 3D printed, 
thus resembling the bands of Büngner. Similar alignment can also be achieved using autologous 
platelet rich fibrin (PRF). As PRF is autologous and enriched with various growth factors, 
including neurotrophins, it would be a great filler material in nerve conduits.   
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